# 2026年1月6日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 美国卫生与公众服务部发布的新宫颈癌筛查指南：强化女性预防性健康

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489823)
**期刊：** JAMA
**PMID：** 41489823
**DOI：** 10.1001/jama.2025.26456

### 第一部分 原文与翻译

**英文原标题：** New Cervical Cancer Screening Guidelines From the US Department of Health and Human Services: Strengthening Women's Preventive Health.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要可用。

### 第二部分 AI 大师评价

该文献报道了美国卫生与公众服务部发布的新宫颈癌筛查指南，旨在更新和优化女性健康预防策略。虽然缺乏摘要细节，但可推测其重点在于基于最新证据改进筛查频率、方法及人群覆盖范围。该指南可能强化了预防健康服务的可及性与公平性，体现了国家层面对女性健康策略的系统性更新。然而，由于缺乏具体数据与方法描述，仍需查阅正式指南原文以全面理解其实践影响。

---

## 2. 深度学习衍生的肌少症标志物可预测RAS野生型转移性结直肠癌患者的抗EGFR治疗获益

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489691)
**期刊：** Clinical cancer research : an official journal of the American Association for Cancer Research
**PMID：** 41489691
**DOI：** 10.1158/1078-0432.CCR-25-3080

### 第一部分 原文与翻译

**英文原标题：** Deep Learning-derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-Type Metastatic Colorectal Cancer

> **英文摘要：**
> PURPOSE: The benefit of treatment intensification in metastatic colorectal cancer (mCRC) may be influenced by host-related factors that are not accounted for in clinical trials or standard care. We investigated the prognostic and predictive value of muscle-bone ratio (MBR), a sarcopenia marker automatically derived from computed tomography (CT) images, in mCRC patients from the prospective PanaMa study and a real-world validation cohort.
> 
> EXPERIMENTAL DESIGN: PanaMa (AIO KRK 0212; NCT01991873) randomized patients with RAS wild-type mCRC, following induction therapy, to maintenance therapy with fluorouracil and folinic acid (FU/FA) with or without panitumumab (Pmab). MBR was automatically calculated from baseline CT images using a validated deep learning model, and patients were stratified by MBR tertiles. Associations with progression-free survival (PFS) and overall survival (OS) were studied using Kaplan-Meier and Cox regression analyses. A retrospective real-world cohort of mCRC patients treated with cetuximab was used for validation.
> 
> RESULTS: Pre-maintenance CT images were available for 189 of 248 randomized patients (76.2%) from PanaMa. In patients receiving FU/FA+Pmab, high MBR was associated with longer PFS (HR 0.43, 95% CI: 0.25-0.73, P=0.002) and OS (HR 0.41, 95% CI: 0.21-0.77, P=0.006), while no association was observed in patients receiving FU/FA alone. Pmab provided a PFS benefit only in patients with high MBR (HR 0.42, 95% CI: 0.24-0.73, P=0.002). The association of high MBR with superior PFS (P=0.002) and OS (P<0.001) was confirmed in the real-world cohort.
> 
> CONCLUSIONS: The benefit of anti-EGFR therapy in mCRC is confined to patients with high MBR. Automated sarcopenia assessment holds promise for personalized treatment intensification in mCRC.

> **中文摘要：**
> 研究目的：转移性结直肠癌（mCRC）治疗强化的获益可能受到宿主相关因素的影响，而这些因素通常未在临床试验或常规治疗中考虑。本研究探讨了从计算机断层扫描（CT）图像自动提取的肌肉骨比（MBR）这一肌少症标志物在mCRC患者中的预后及预测价值，研究对象包括前瞻性PanaMa研究和真实世界验证队列。
> 
> 实验设计：PanaMa（AIO KRK 0212；NCT01991873）研究将接受诱导治疗后的RAS野生型mCRC患者随机分配至使用或不使用帕尼单抗（Pmab）的氟尿嘧啶/亚叶酸（FU/FA）维持治疗组。MBR通过经验证的深度学习模型从基线CT图像中自动计算，患者按MBR三分位分层。采用Kaplan-Meier法及Cox回归分析评估其与无进展生存期（PFS）及总生存期（OS）的关系。另纳入一项接受西妥昔单抗治疗的mCRC患者回顾性真实世界队列进行验证。
> 
> 研究结果：在PanaMa研究中，248例随机患者中有189例（76.2%）获得了维持治疗前的CT图像。接受FU/FA+Pmab治疗的患者中，高MBR者PFS更长（HR 0.43, 95% CI: 0.25–0.73, P=0.002），OS也延长（HR 0.41, 95% CI: 0.21–0.77, P=0.006）；而单用FU/FA者未见相关性。Pmab仅在高MBR患者中显示PFS获益（HR 0.42, 95% CI: 0.24–0.73, P=0.002）。真实世界队列验证了高MBR与更优PFS（P=0.002）及OS（P<0.001）的相关性。
> 
> 结论：抗EGFR治疗的获益局限于高MBR的mCRC患者。自动化的肌少症评估为mCRC个体化治疗强化提供了新的可能。

### 第二部分 AI 大师评价

该研究结合前瞻性临床试验与真实世界数据，利用深度学习模型从CT图像自动计算肌肉骨比（MBR），探索其在RAS野生型转移性结直肠癌抗EGFR治疗中的预测价值。结果显示，仅高MBR患者从帕尼单抗或西妥昔单抗治疗中获益，提示宿主体成分对疗效具有关键影响。研究创新性地将人工智能影像分析用于精准肿瘤学决策，但结果仍需在多中心和不同人群中进一步验证。

---

## 3. 单细胞与空间组学分析揭示结核病诱导的肌成纤维细胞是肺病理的关键驱动因子

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489684)
**期刊：** The Journal of experimental medicine
**PMID：** 41489684
**DOI：** 10.1084/jem.20251067

### 第一部分 原文与翻译

**英文原标题：** Single-cell and spatial profiling highlights TB-induced myofibroblasts as drivers of lung pathology.

> **英文摘要：**
> Tuberculosis (TB) typically causes lung destruction and fibrosis, leading to ∼1.3 million deaths annually. The cellular drivers of human TB immunopathology remain poorly defined. We performed single-cell RNA sequencing and spatial transcriptomics on lung tissues from TB-infected and TB-negative individuals, identifying 30 distinct immune, parenchymal, and stromal cell subsets. Several were linked to TB pathology and corroborated through immunohistochemistry, flow cytometry, and independent human datasets. Fibroblasts were identified as major drivers in both active TB granuloma and TB-diseased lung tissue. In particular, the MMP1+CXCL5+ fibroblast subset, expressing a myofibroblast-like gene signature, was associated with severe disease and higher bacterial burden in nonhuman primate granulomas. Network analyses revealed cross talk between MMP1+CXCL5+ fibroblasts and SPP1+ macrophages within the granuloma cuff, which has been reported in other disease contexts, and may play an important role in TB immunopathology. Our findings highlight previously unappreciated cell populations and potential targets for novel TB therapies.

> **中文摘要：**
> 结核病（TB）通常会导致肺组织破坏和纤维化，每年约造成 130 万人死亡。人类结核病免疫病理的细胞驱动因素仍然缺乏明确界定。我们对结核感染者和结核阴性个体的肺组织进行了单细胞 RNA 测序及空间转录组学分析，识别出 30 种不同的免疫、实质及基质细胞亚群。其中若干细胞群与结核病理过程相关，这些关联通过免疫组织化学、流式细胞术及独立的人类数据集得到验证。在活动性结核肉芽肿及结核病变肺组织中，成纤维细胞被鉴定为主要的病理驱动细胞。特别是表达 MMP1+CXCL5+ 的成纤维细胞亚群，其呈现出类似肌成纤维细胞的基因特征，与严重疾病程度及非人灵长类肉芽肿中更高的细菌负荷相关。网络分析显示，在肉芽肿外围区域存在 MMP1+CXCL5+ 成纤维细胞与 SPP1+ 巨噬细胞之间的相互通讯，这种相互作用在其他疾病背景下亦有报道，可能在结核免疫病理中发挥重要作用。本研究揭示了此前未被充分认识的细胞群体，并指出了结核新疗法的潜在靶点。

### 第二部分 AI 大师评价

本研究通过结合单细胞 RNA 测序与空间转录组学技术，系统揭示了结核病肺组织中多种免疫及基质细胞的组成及其相互作用。研究发现，MMP1+CXCL5+ 肌成纤维样成纤维细胞是结核病肺损伤与纤维化的关键驱动因子，并与巨噬细胞的信号互作共同塑造病理微环境。此发现拓展了对结核免疫病理机制的理解，并为抗纤维化与免疫调控类治疗策略提供了新方向。研究的创新性体现在空间多组学整合与人-非人灵长类对照验证，但局限在于缺乏功能性干预验证以确认其因果作用。

---

## 4. LINE-1 位点转录促进致癌染色质结构的形成

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489510)
**期刊：** Cancer discovery
**PMID：** 41489510
**DOI：** 10.1158/2159-8290.CD-25-1085

### 第一部分 原文与翻译

**英文原标题：** LINE-1 Locus Transcription Nucleates Oncogenic Chromatin Architecture.

> **英文摘要：**
> Retrotransposons are genomic parasites frequently reactivated in cancers, where their mobility can cause genetic alterations. However, it remains unclear whether their gene products contribute to cancer beyond mutagenesis. Here, we uncover a chromatin-associated function of RNAs from Long Interspersed Element-1 (LINE-1), the only autonomous retrotransposon in the human genome. Subcellular-resolved transcriptomics revealed that LINE-1 RNAs are primarily nascent transcripts produced by full-length, cell-type-specific genomic copies of evolutionarily young subfamilies. Using a long-read chromosome conformation assay, we identified a class of highly interactive LINE-1 loci required for gene expression across cancer subtypes, revealing an unexpected regulatory role for LINE-1 locus transcription in oncogenic gene control. LINE-1 RNA depletion disrupted LINE-1-centric chromatin interactions and downregulated associated genes, whereas genomic insertion of an inducible LINE-1 generated de novo chromatin interactions in a transcription-dependent manner. Therefore, beyond their mutagenic potential, retrotransposons also regulate cancer gene expression by nucleating chromatin architecture through their transcriptional activity.

> **中文摘要：**
> 反转录转座子是基因组寄生元件，在癌症中常常被重新激活，其移动性可能导致遗传改变。然而，目前尚不清楚其基因产物是否在诱变之外对癌症发生有贡献。在本研究中，我们揭示了人类基因组中唯一具有自主活性的反转录转座子——长散在核元件1（LINE-1）的RNA所具备的染色质相关功能。亚细胞分辨率的转录组学分析显示，LINE-1 RNA主要是由进化上较新的亚家族的全长基因拷贝生成的细胞类型特异性新生转录产物。通过基于长读长的染色体构象分析，我们鉴定出一类高度互作的LINE-1位点，这些位点对多种癌症亚型中的基因表达是必需的，从而揭示了LINE-1位点转录在致癌基因调控中的一种出乎意料的调节作用。沉降LINE-1 RNA会破坏以LINE-1为中心的染色质互作并下调相关基因，而在基因组中插入一个可诱导的LINE-1则可在依赖转录的情况下新生成染色质互作。因此，反转录转座子不仅具有诱变潜能，还通过其转录活性诱导染色质结构的形成，从而调控癌症基因的表达。

### 第二部分 AI 大师评价

本研究探讨了LINE-1反转录转座子在癌症基因调控中的非诱变性功能。作者通过亚细胞分辨转录组学与长读长染色体构象分析，发现进化上较新的LINE-1位点通过其转录产物促进染色质互作并调控癌基因表达。该发现表明LINE-1不仅是基因组不稳定性的来源，同时还是致癌染色质结构的重要组织者。研究在机制层面填补了转座子转录功能的空白，揭示了癌基因表达调控的新维度，但具体的调控网络和临床意义仍需进一步验证。

---

## 5. 空间分辨多组学揭示成釉细胞型颅咽管瘤中的代谢重塑与自噬激活

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489092)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41489092
**DOI：** 10.1002/advs.202516965

### 第一部分 原文与翻译

**英文原标题：** Spatially Resolved Multiomics Reveals Metabolic Remodeling and Autophagy Activation in Adamantinomatous Craniopharyngiomas.

> **英文摘要：**
> Adamantinomatous craniopharyngioma (ACP), a benign yet highly recurrent and therapy-resistant intracranial tumor, remains a considerable clinical challenge because of its complex pathological structure, infiltrative growth, and limited treatment options. Here, integrated spatially resolved multiomics is employed-including single-cell spatial transcriptomics via CosMx SMI and spatially resolved metabolomics via AFADESI-MSI, accompanied by bulk metabolomics and functional validation-to unravel the driving factors of ACP progression and recurrence. Analysis results reveal three interdependent biological hallmarks: first, the spatial segregation and molecular heterogeneity of 10 distinct tumor epithelial cell subpopulations within the ACP, each of which presents unique transcriptional signatures; second, in tumor regions and recurrent tumor epithelium tissues, stronger transporter-mediated choline/ethanolamine uptake from cystic fluid and significant upregulation of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) synthesis is observed, creating the enhanced "cystic fluid-tumor cell" and "choline/ethanolamine-PC/PE" metabolic axis, and demonstrating the spatial metabolic remodeling of ACP; and third, this metabolic axis directly couples to autophagy activation of corresponding regions in ACP tissue, which is validated by multi-immunohistochemistry for Beclin1 and GABARAP. Together, these findings reveal metabolic remodeling and autophagic activation as critical drivers of ACP progression and recurrence and provide an opportunity for precise biomarker-driven treatment of this intractable tumor.

> **中文摘要：**
> 成釉细胞型颅咽管瘤（ACP）是一种良性但高度复发且对治疗具有抵抗性的颅内肿瘤，由于其复杂的病理结构、浸润性生长以及有限的治疗选择，仍然是一个重大的临床挑战。本研究采用整合的空间分辨多组学方法——包括通过 CosMx SMI 实现的单细胞空间转录组学及通过 AFADESI-MSI 实现的空间分辨代谢组学，并结合总体代谢组学及功能验证——以揭示驱动 ACP 进展和复发的关键因素。分析结果揭示了三个相互关联的生物学特征：其一，在 ACP 内部发现 10 个不同的肿瘤上皮细胞亚群，具有空间分隔和分子异质性，每个亚群均呈现独特的转录特征；其二，在肿瘤区域及复发性肿瘤上皮组织中，观察到经转运体介导的从囊液中摄取胆碱/乙醇胺的能力增强，以及磷脂酰胆碱（PC）和磷脂酰乙醇胺（PE）合成显著上调，从而形成增强的“囊液-肿瘤细胞”及“胆碱/乙醇胺-PC/PE”代谢轴，展示出 ACP 的空间代谢重塑特征；其三，该代谢轴与 ACP 组织相应区域的自噬激活直接耦合，这一现象通过 Beclin1 和 GABARAP 的多重免疫组化检测得到验证。综合而言，这些发现揭示了代谢重塑和自噬激活是驱动 ACP 进展与复发的关键因素，并为这种难治性肿瘤提供了基于精确生物标志物的治疗新契机。

### 第二部分 AI 大师评价

该研究针对成釉细胞型颅咽管瘤这一难治性肿瘤，利用空间分辨多组学技术系统解析其代谢与自噬的空间互作机制。研究创新地结合单细胞空间转录组学与空间代谢组学，揭示了肿瘤亚群的分子异质性及其与代谢重塑和自噬激活的关联。发现代谢轴与囊液成分及自噬活化密切耦合，丰富了对肿瘤复发机制的理解。其创新性在于首次建立了 ACP 的空间代谢-自噬联动图谱，但仍需更大样本及功能研究以验证其临床潜在应用。

---

## 6. 穿刺过程中实时体内细胞级成像

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489070)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41489070
**DOI：** 10.1002/advs.202515110

### 第一部分 原文与翻译

**英文原标题：** Real-Time In Vivo Cellular-Level Imaging During Puncture.

> **英文摘要：**
> In the pursuit of precise disease diagnosis, accurate tissue sampling during biopsy is critical. Current CT/ ultrasound-guided biopsies provide macroscopic localization but lack real-time cellular-resolution visualization during puncture, particularly for deep, narrow lumens or small lesions, thereby increasing false-negative and nondiagnostic sampling risks. It's desired to have a puncture with microscopy imaging. Here, we demonstrate an artificial-intelligence-empowered integrative-light-field microendoscopy (AIM) needle. This photonic-mechanically co-engineered probe overcomes dynamic diffraction limits via a closed-loop adaptive optics system integrated in a 25G biopsy needle, enabling diffraction-limited imaging during in vivo puncture. AIM needle resolved characteristic layered microstructures throughout mouse organs (parenchymal/hollow) and pulmonary tumors via synergistic light-field modulation, leveraging K-means and convolutional neural networks to enable in situ pathology-like analysis and tumor/normal tissue discrimination along puncture paths. AIM needle demonstrates dual clinical potential as a complement to macroscopic guidance: potentially providing histology-like feedback without interrupting procedures while enhancing biopsy targeting accuracy through navigation integration, reducing false-negative rates in narrow lumens and microlesions, thereby improving early detection sensitivity.

> **中文摘要：**
> 在追求精确疾病诊断的过程中，活检中的准确组织取样至关重要。当前的CT/超声引导活检可实现宏观定位，但在穿刺过程中缺乏实时细胞分辨率的可视化，尤其是对于深部、狭窄腔道或微小病灶，从而增加了假阴性和无诊断性取样的风险。理想情况是能够在穿刺过程中实现显微级成像。本文展示了一种由人工智能驱动的集成光场微内窥针（AIM针）。该光机协同设计的探针通过封闭回路自适应光学系统克服了动态衍射极限，并被集成于25G活检针中，从而在体内穿刺过程中实现衍射极限成像。AIM针基于光场调制的协同作用，在小鼠器官（实质性/空腔性）以及肺部肿瘤中解析了典型的分层微结构，并利用K-means聚类和卷积神经网络实现了类原位病理分析与沿穿刺路径的肿瘤/正常组织区分。AIM针显示出作为宏观引导补充的双重临床潜力：在不干扰操作的情况下提供类组织学反馈，同时通过导航集成提高活检定位精度，降低狭窄腔道和微小病灶的假阴性率，从而提升早期检测灵敏度。

### 第二部分 AI 大师评价

该研究旨在解决传统影像引导活检缺乏细胞级实时成像的问题。作者开发了一种融合人工智能和光学工程的AIM微内窥针，实现了穿刺过程中的衍射极限成像。实验结果显示该系统可识别动物模型中不同组织的微结构，并利用深度学习算法实现肿瘤与正常组织的快速区分。该技术在实时活检导航与“原位病理式”评估方面具有显著创新性，但其临床推广仍需验证系统稳定性、成像速度与人体安全性。

---

## 7. 镓掺杂MXene纳米酶通过阻断多种细胞死亡途径并促进肝细胞再生实现肝脏保护

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41487076)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41487076
**DOI：** 10.1002/advs.202509079

### 第一部分 原文与翻译

**英文原标题：** Gallium-Doped MXene Nanozymes Protect Liver Through Multi-Death Pathway Blockade and Hepatocyte Regeneration.

> **英文摘要：**
> Acetaminophen-induced liver injury (AILI) is a major cause of acute liver failure, yet single-target therapies like N-acetylcysteine remain inadequate due to its complex pathogenesis. To address this challenge, we propose a dual-action defense-regeneration strategy that concurrently blocks multi-death pathways and promotes hepatocyte regeneration. Specifically, the therapeutic metal gallium is doped into VC MXene nanozymes (Ga-VC) to surpass conventional nanozymes by integrating sustained antioxidant activity for death signaling blockade, multi-pathway regulation of cell death networks, and activation of pro-regenerative molecules. In vivo, Ga-VC nanozymes exhibited superior protective efficacy over N-acetylcysteine against AILI. Mechanistic investigations revealed that the Ga-VC nanozymes disrupt the synergistic amplification of liver injury by simultaneously inhibiting three key death pathways: oxidative stress (via ROS scavenging, reduce JNK phosphorylation, and activated Nrf2/HO-1), apoptosis (via restored Bcl-2/Bax balance), and ferroptosis (by suppressed iron-dependent lipid peroxidation and upregulated SLC7A11/FTH1/FTL1). Notably, Ga-VC nanozymes fostered a pro-regenerative microenvironment by activating Wnt/βCAT pathways signaling and key cell cycle drivers (CCND1, MYC, PCNA), thereby enhancing hepatocyte regeneration. This work not only offers a promising therapeutic approach for AILI but also significantly expands the scope of nanozyme-based therapeutics for complex diseases requiring multi-target intervention.

> **中文摘要：**
> 对乙酰氨基酚诱导的肝损伤（AILI）是急性肝功能衰竭的主要原因，但由于其发病机制复杂，单一靶点治疗如乙酰半胱氨酸疗效仍不理想。为应对此挑战，本研究提出一种兼具防御和再生双重作用的策略，同时阻断多种细胞死亡途径并促进肝细胞再生。具体而言，将治疗性金属镓掺杂于VC MXene纳米酶（Ga-VC）中，使其超越传统纳米酶，通过整合持续的抗氧化活性以阻断死亡信号、调控多种细胞死亡通路网络并激活促再生分子。在体内实验中，Ga-VC纳米酶对抗AILI的保护效果优于乙酰半胱氨酸。机制研究表明，Ga-VC纳米酶通过同时抑制三种关键细胞死亡通路来破坏肝损伤的协同放大效应：氧化应激（通过清除ROS、降低JNK磷酸化并激活Nrf2/HO-1通路）、凋亡（通过恢复Bcl-2/Bax平衡）以及铁死亡（通过抑制铁依赖性脂质过氧化并上调SLC7A11/FTH1/FTL1）。值得注意的是，Ga-VC纳米酶还能通过激活Wnt/β-CAT通路信号及关键细胞周期驱动因子（CCND1、MYC、PCNA），从而促进肝细胞再生并形成促再生的微环境。本研究不仅提供了一种有前景的AILI治疗新策略，也显著拓展了基于纳米酶的多靶点复杂疾病治疗的研究边界。

### 第二部分 AI 大师评价

该研究针对对乙酰氨基酚诱导的急性肝损伤，设计了一种兼顾防御与再生的双功能纳米酶策略。通过将镓掺杂于MXene结构中，研究实现了对氧化应激、凋亡与铁死亡三条细胞死亡通路的协同阻断，同时激活肝细胞再生相关信号。动物实验显示其保护效果显著优于传统药物乙酰半胱氨酸。该工作创新性地拓展了纳米酶在多靶点复杂疾病治疗中的应用，但其长期生物相容性与临床转化仍需进一步验证。

---

## 8. HiST：通过多尺度融合深度学习从组织学图像重建肿瘤空间转录组。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41487073)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41487073
**DOI：** 10.1002/advs.202514351

### 第一部分 原文与翻译

**英文原标题：** HiST: Histological Images Reconstruct Tumor Spatial Transcriptomics via MultiScale Fusion Deep Learning.

> **英文摘要：**
> Spatial transcriptomics (ST) provides valuable insights into the tumor microenvironment by integrating molecular features with spatial context; however, its clinical utility is limited by high costs. To address this, we develop a multi-scale convolutional deep learning framework, HiST, which utilizes ST to learn the relationship between spatially resolved gene expression profiles (GEPs) and histological morphology. HiST accurately predicts tumor regions across multiple cancer types (e.g., breast cancer; area under the curve: 0.96), demonstrating high concordance with pathologist annotations. Moreover, HiST reconstructs spatially resolved GEPs from histological images with an average Pearson correlation coefficient of 0.74 across five cancer types, outperforming existing models by about two-fold. These high-fidelity spatial GEPs enable tumor heterogeneity assessment from histological images, including identification of tumor subtypes with distinct DNA copy number variations. We demonstrate the clinical utility of the predicted GEPs, which robustly stratify patient prognosis across five cancer types from The Cancer Genome Atlas (e.g., breast cancer; concordance index: 0.78). The predicted profiles further facilitate immunotherapy response prediction and enrichment analyses of relevant biological pathways and markers. Collectively, HiST achieves state-of-the-art performance in spatial GEP reconstruction, providing a reliable molecular representation that enhances downstream tasks such as tumor profiling and clinical analyses.

> **中文摘要：**
> 空间转录组学（ST）通过整合分子特征与空间背景，为肿瘤微环境提供了有价值的洞察；然而，其临床应用受高成本限制。为解决这一问题，我们开发了一个多尺度卷积深度学习框架——HiST，该框架利用 ST 学习空间分辨的基因表达谱（GEPs）与组织形态学之间的关系。HiST 能够在多种癌症类型中（例如乳腺癌，曲线下面积 AUC：0.96）准确预测肿瘤区域，并与病理学家标注结果高度一致。此外，HiST 能够从组织学图像中重建空间分辨的 GEPs，在五种癌症类型中的平均皮尔逊相关系数为 0.74，性能约为现有模型的两倍。这些高保真空间 GEPs 使得可以从组织学图像中评估肿瘤异质性，包括识别具有不同 DNA 拷贝数变异的肿瘤亚型。我们进一步证明了预测 GEPs 的临床实用性，其可在癌症基因组图谱（TCGA）中五种癌症类型中稳健地分层患者预后（例如乳腺癌，一致性指数 CI：0.78）。预测的基因表达特征还促进了免疫治疗反应预测及相关生物通路和标志物的富集分析。总体而言，HiST 在空间 GEP 重建方面达到了当前最先进的性能，提供了可靠的分子表征，可增强肿瘤分型与临床分析等下游任务。

### 第二部分 AI 大师评价

该研究提出了基于多尺度深度学习的 HiST 框架，旨在通过组织学图像重建肿瘤空间转录组，实现低成本获取分子信息。模型在多种癌症类型中表现优异，显著优于现有方法，并能辅助肿瘤分型、预后评估及免疫治疗反应预测。研究的创新性在于实现了由常规病理图像到高维转录数据的跨模态重建，为组织病理学的分子层面解析提供了新思路。其局限性可能在于数据依赖性较高及外部样本的泛化能力仍需进一步验证。

---

## 9. NAD 依赖性酶 SIRT3 通过 NAD 合成途径限制结直肠癌中肠上皮细胞功能

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41487042)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41487042
**DOI：** 10.1002/advs.202512532

### 第一部分 原文与翻译

**英文原标题：** NAD-Dependent Enzyme SIRT3 Limits Intestinal Epithelial Cell Functions Through NAD Synthesis Pathway in Colorectal Cancer.

> **英文摘要：**
> Intestinal epithelial cells (IEC) are crucial for regulating intestinal local immunity to potentiate mucosal barrier function, but the mechanism remains unclear. In this study, we showed that the nicotinamide adenine dinucleotide (NAD)-dependent enzyme SIRT3 in IECs is required for local T cell differentiation in colorectal cancer and colitis. Modest IEC SIRT3 overexpression reduces the secretion of proinflammatory cytokine IL-1β and inhibits IFNγ-producing CD4T cells (T1) and cytotoxic T lymphocytes (CTLs) differentiation. IEC SIRT3 deficiency enhances the production of IL-1β and promotes local T1 and CTL differentiation in limiting colorectal cancer growth and aggravating colitis. Mechanistically, SIRT3 deficiency promotes IEC functions through quinolinic acid (QA)-mediated NAD synthesis for limiting tumor growth. Microbiota-derived 3-hydroxyaminobenzoic acid is the source of intracellular QA in IECs. IL-1β-IL-1R1 signaling is required for IEC SIRT3 deficiency-induced T1 and CTL differentiation in cancer. Thus, our findings showed that microbiota-derived QA is used as an alternative source of replenishing the intracellular NAD pool induced by SIRT3 deficiency to regulate IEC and T cell function, which has implications for targeting IECs as an approach to the treatment of immune-associated diseases, including colorectal cancer and colitis.

> **中文摘要：**
> 肠上皮细胞（IEC）在调节肠道局部免疫、增强黏膜屏障功能方面至关重要，但其机制尚不清楚。本研究显示，肠上皮细胞中烟酰胺腺嘌呤二核苷酸（NAD）依赖性酶 SIRT3 对结直肠癌和结肠炎中的局部 T 细胞分化是必需的。适度过表达 IEC SIRT3 可降低促炎细胞因子 IL-1β 的分泌，并抑制产生 IFNγ 的 CD4T 细胞（T1）及细胞毒性 T 淋巴细胞（CTL）的分化。IEC SIRT3 缺失则增强 IL-1β 的产生，促进局部 T1 和 CTL 分化，从而限制结直肠癌的生长并加重结肠炎。从机制上看，SIRT3 缺失通过喹啉酸（QA）介导的 NAD 合成途径增强 IEC 功能，从而限制肿瘤生长。来源于肠道菌群的 3-羟氨基苯甲酸是 IEC 内源性 QA 的来源。IL-1β-IL-1R1 信号通路对于 IEC SIRT3 缺失诱导的癌症中 T1 和 CTL 分化是必需的。因此，我们的研究发现，源自肠道菌群的 QA 可作为一种替代来源，用以补充 SIRT3 缺失引起的细胞内 NAD 储备，从而调节 IEC 和 T 细胞功能，这为靶向 IEC 治疗包括结直肠癌和结肠炎在内的免疫相关疾病提供了新的启示。

### 第二部分 AI 大师评价

本研究揭示了 NAD 依赖性去乙酰化酶 SIRT3 在肠上皮细胞中通过 NAD 合成途径调控肿瘤免疫微环境的关键作用。作者系统解析了 IEC SIRT3 对 T 细胞分化及促炎因子 IL-1β 表达的双向调控，并阐明了喹啉酸途径在 SIRT3 缺失后维持 NAD 水平和促进抗肿瘤免疫中的作用。研究创新性地连接了宿主代谢、肠道菌群代谢物与肿瘤免疫反应，为结直肠癌和炎症性肠病的代谢免疫治疗提供了潜在靶点。但其结果仍需在人类模型中验证，以进一步明确临床转化价值。

---

## 10. 红细胞通过凋亡小体内化细胞外 DNA 并与癌症患者具有临床相关性

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486873)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486873
**DOI：** 10.1002/advs.202511408

### 第一部分 原文与翻译

**英文原标题：** Red Blood Cells Internalize Extracellular DNA via Apoptotic Bodies with Clinical Relevance to Cancer Patients.

> **英文摘要：**
> Mature red blood cells (RBCs), the most abundant anucleate cells in humans, have long been overlooked as DNA carriers. Recent evidence implicates RBC-derived DNA (rbcDNA) as a potential biomarker for cancer diagnostics, yet its origin and how RBCs acquire tumor DNA remain poorly understood. Here, we find that mature RBCs harbor short DNA fragments distinct from genomic DNA. Both in vivo and in vitro experiments confirm that RBCs can internalize extracellular DNA and reflect tumor burden. Oxford Nanopore sequencing of rbcDNA reveals that short rbcDNA fragments are homologous to extracellular cell-free DNA (cfDNA). We identify apoptotic bodies (apoBDs) as key mediators of extracellular DNA uptake by RBCs, triggering RBC deformation, Heinz body formation, oxidative stress, and vesiculation. Tumor apoBD-treated RBCs are rapidly cleared in vivo via a partly macrophage-dependent effect, causing local immunosuppression in the spleen. Clinically, rbcDNA shows no advantage in detecting driver mutations compared with cfDNA, but its abundance significantly correlates with tumor burden and treatment response. Overall, our findings offer novel insights into RBC biology and support rbcDNA's clinical application in liquid biopsy.

> **中文摘要：**
> 成熟的红细胞（RBCs）是人体中数量最为丰富的无核细胞，长期以来被忽视为 DNA 载体。最新证据表明，来源于红细胞的 DNA（rbcDNA）可能成为癌症诊断的潜在生物标志物，但其来源以及红细胞如何获得肿瘤 DNA 仍然知之甚少。在本研究中，我们发现成熟红细胞中存在与基因组 DNA 不同的短片段 DNA。体内与体外实验均证实，红细胞能够内化细胞外 DNA，并能反映肿瘤负荷。通过牛津纳米孔测序分析 rbcDNA 显示，这些短片段与细胞外游离 DNA（cfDNA）具有同源性。我们鉴定出凋亡小体（apoBDs）是红细胞摄取细胞外 DNA 的关键介导者，该过程会引发红细胞形变、Heinz 小体形成、氧化应激以及囊泡化。经肿瘤 apoBD 处理的红细胞在体内会通过部分依赖巨噬细胞的机制被快速清除，导致脾脏局部免疫抑制。在临床上，与 cfDNA 相比，rbcDNA 在驱动突变检测方面没有优势，但其丰度与肿瘤负荷及治疗反应显著相关。总体而言，我们的研究为红细胞生物学提供了新的见解，并支持 rbcDNA 在液体活检中的潜在临床应用价值。

### 第二部分 AI 大师评价

该研究旨在揭示红细胞摄取细胞外 DNA 的机制及其在癌症检测中的潜在临床意义。研究者通过体内外实验和纳米孔测序验证，凋亡小体在红细胞吸收 cfDNA 过程中起关键作用，并导致红细胞形态和免疫相关改变。结果指出，rbcDNA 可反映肿瘤负荷但在突变识别上无明显优势。此研究创新性地扩展了红细胞在肿瘤液体活检中的应用视角，但仍需进一步探索其在不同癌症类型中的特异性与稳定性。

---

## 11. 近红外光驱动光催化抗菌水凝胶用于协同清除耐甲氧西林金黄色葡萄球菌生物膜及促进创面再生

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486853)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486853
**DOI：** 10.1002/advs.202518215

### 第一部分 原文与翻译

**英文原标题：** NIR Light-Driven Photocatalytic Antibacterial Hydrogels for Synergistic MRSA Biofilm Eradication and Wound Regeneration.

> **英文摘要：**
> The treatment of drug-resistant bacterial biofilm infections remains a significant challenge in clinical practice. To address this challenge, 3D oxygen vacancy (OV)-rich iron-doped BiOS (Fe-BiOS, Fe-BOS) nanoflowers (NFs) are synthesized for the first time via an ion-exchange method. The resulting material exhibits a small band gap, abundant OVs, and favorable charge-transfer properties. It also shows robust photothermal performance and strong photocatalytic reactive oxygen species (ROS)-generation ability. Fe-BOS@C/H Gel is subsequently prepared by crosslinking hydrazide-modified chondroitin sulfate, the Fe-BOS NFs, and oxidized hyaluronic acid via a dynamic Schiff reaction. Fe-BOS@C/H Gel not only shows good hemostasis and injectability, but also achieves 97% methicillin-resistant Staphylococcus aureus (MRSA) biofilm elimination. Transcriptomic analyses reveal that Fe-BOS@C/H Gel operates through multiple antibacterial mechanisms, including the destruction of bacterial membranes and the regulation of oxidative stress pathways and metabolic networks. In vitro cell experiments show that Fe-BOS@C/H Gel promotes cell proliferation and migration. In a mouse model of MRSA biofilm-infected wounds, Fe-BOS@C/H Gel under NIR light eliminates MRSA biofilm through localized high temperature and ROS storms, and promotes collagen deposition and angiogenesis without NIR light. This study provides an innovative solution that utilizes the synergistic strategy of "light-driven antibacterial performance and pro-regeneration" to treat drug-resistant bacterial-infected wounds.

> **中文摘要：**
> 耐药性细菌生物膜感染的治疗仍是临床实践中的重要挑战。为应对此挑战，作者首次采用离子交换法合成了富含氧空位（OV）的铁掺杂BiOS（Fe-BiOS，Fe-BOS）三维纳米花（NFs）。所获得的材料表现出窄带隙、丰富的氧空位及优异的电荷传递特性。同时，该材料展示出强劲的光热性能和较强的光催化活性氧（ROS）生成能力。随后，研究者通过动态席夫碱反应，将肼改性硫酸软骨素、Fe-BOS纳米花及氧化透明质酸交联，制备了Fe-BOS@C/H水凝胶。该水凝胶不仅具有良好的止血性和可注射性，还能实现97%的耐甲氧西林金黄色葡萄球菌（MRSA）生物膜清除率。转录组学分析显示，Fe-BOS@C/H水凝胶通过多重抗菌机制发挥作用，包括破坏细菌膜结构以及调控氧化应激通路和代谢网络。体外细胞实验表明，该水凝胶能促进细胞增殖与迁移。在MRSA生物膜感染的小鼠创面模型中，Fe-BOS@C/H水凝胶在近红外光照射下通过局部高温和ROS风暴清除MRSA生物膜，而在无光条件下亦能促进胶原沉积和血管生成。本研究提出了一种将“光驱动抗菌性能与促再生”相结合的创新策略，为治疗耐药性细菌感染创面提供了新思路。

### 第二部分 AI 大师评价

该研究旨在开发一种基于近红外光响应的光催化抗菌水凝胶，用于高效清除MRSA生物膜并促进创面修复。研究者通过离子交换法构建富氧空位的Fe-BOS纳米花，赋予材料光热与ROS双重效应，再与多糖基质交联形成可注射水凝胶。该复合材料兼具止血、抗菌及促愈合功能，在体内外实验中均表现出显著疗效。创新点在于实现了光触发抗菌与组织再生的协同，局限性可能在于应用的光穿透深度和大动物模型验证仍需进一步研究。

---

## 12. 干扰YAP凝聚体的形成可促进AMPKα的激活以抑制原发性肝癌的进展

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486777)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486777
**DOI：** 10.1002/advs.202512866

### 第一部分 原文与翻译

**英文原标题：** Disrupting the Formation of YAP Condensates Promotes the Activation of AMPKα to Inhibit the Progression of Primary Liver Cancer.

> **英文摘要：**
> Liquid-liquid phase separation, a process facilitating biomolecular condensate formation, plays a critical role in various pathologies, including tumorigenesis, metabolic disorders, and neurodegenerative diseases. Dysregulated phase separation has been linked to tumor initiation and progression. However, the pathological significance of phase separation in primary tumors of mice remains largely unexplored. We constructed a series of primary liver cancer models via hydrodynamic tail vein injection and confirmed that endogenous Yes-associated protein (YAP) formed numerous condensates in primary liver cancer of mice. Deletion, mutagenesis, and replacement assays confirmed that the formation of YAP condensates plays a critical role in the development of cellular myelocytomatosis oncogene (c-Myc)-induced hepatocellular carcinoma, myristoylated AKT (myr-AKT)-induced intrahepatic cholangiocarcinoma, and amino-terminal missing first 90 amino acids of catenin beta 1 (ΔN90-CTNNB1)-induced hepatoblastoma. We found that the YAP phase separation inhibits the activation of the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway, thereby promoting the occurrence and development of primary liver cancer. Additionally, we identified that the TEA domain transcription factor 1 (TEAD1)-derived peptide effectively disrupted YAP condensate formation, leading to AMPKα activation in vivo and inhibition of primary liver cancer progression. This study systematically confirms that YAP phase separation plays a crucial role in the progression of various primary liver cancers and further substantiates that strategic disruption of these condensates constitutes an effective treatment for primary liver cancer in vivo.

> **中文摘要：**
> 液-液相分离是一种促进生物大分子凝聚体形成的过程，在包括肿瘤发生、代谢紊乱及神经退行性疾病在内的多种病理过程中发挥关键作用。相分离的异常调控已被证明与肿瘤的起始和进展相关。然而，相分离在小鼠原发性肿瘤中的病理学意义仍 largely 未被深入研究。我们通过水动力尾静脉注射建立了一系列小鼠原发性肝癌模型，并证实内源性Yes相关蛋白（YAP）在小鼠原发性肝癌中形成了大量凝聚体。通过缺失、突变和替换实验验证了YAP凝聚体的形成在细胞髓样癌基因（c-Myc）诱导的肝细胞癌、肉豆蔻酰化AKT（myr-AKT）诱导的肝内胆管癌以及去除β-连环蛋白（catenin beta 1, CTNNB1）氨基端前90个氨基酸突变型（ΔN90-CTNNB1）诱导的肝母细胞瘤发展中起关键作用。我们发现，YAP的相分离抑制了腺苷单磷酸激活蛋白激酶（AMPK）信号通路的激活，从而促进了原发性肝癌的发生与发展。此外，我们鉴定出来源于TEA结构域转录因子1（TEAD1）的肽能够有效破坏YAP凝聚体的形成，进而在体内激活AMPKα并抑制原发性肝癌的进程。本研究系统证实YAP相分离在多种原发性肝癌进展中发挥关键作用，并进一步表明有策略地破坏这些凝聚体是原发性肝癌体内治疗的有效途径。

### 第二部分 AI 大师评价

该研究通过多种小鼠原发性肝癌模型系统性揭示了YAP相分离在肝癌进展中的关键作用，发现其可通过抑制AMPK信号途径促进肿瘤发展。研究利用基因缺失及突变实验阐明了YAP凝聚体形成与多种肝癌类型（c-Myc、myr-AKT、ΔN90-CTNNB1诱导型）之间的因果关系。进一步发现TEAD1来源肽可破坏YAP凝聚体，从而激活AMPKα并在体内抑制肝癌进展。该成果不仅深化了对相分离参与肿瘤发生机制的理解，也为干预YAP凝聚体提供了潜在治疗新策略。然而，其临床转换仍需在更高模型验证和药物递送方向上进一步研究。

---

## 13. SETD2调控的核糖体稳态维持肠道上皮屏障的完整性

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486761)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486761
**DOI：** 10.1002/advs.202508168

### 第一部分 原文与翻译

**英文原标题：** Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier.

> **英文摘要：**
> Strict regulation of epithelial cells is crucial for maintaining intestinal barrier integrity and preventing intestinal diseases. While transcriptional regulation is well recognized as vital in this process, translational regulation is equally important. SETD2, a methyltransferase, is involved in transcriptional regulation to maintain intestinal epithelial barrier function. However, its role in translation remains largely unexplored. Here, we found SETD2 deficiency leads to the downregulation of ribosome biogenesis progress coupled with transcriptome-proteome discordance. Further ribosome profiling sequencing analyses showed reduced translational efficiency of cell adhesion and junction signatures in impaired intestinal epithelial barrier. Mechanistically, SETD2 ablation causes dysregulation and recruitment disorders of ribosome biogenesis factors, impairing the composition and distribution of ribosomal proteins. This disruption of ribosome biogenesis and homeostasis results in translational disorder of barrier maintenance genes, thereby compromising the intestinal barrier. Collectively, our findings unveil a previously unappreciated role of ribosome biogenesis and translational regulation in safeguarding intestinal epithelial barrier, and disclose a previously undiscovered role of SETD2 in modulating ribosome homeostasis.

> **中文摘要：**
> 对上皮细胞的严格调控对于维持肠道屏障的完整性和预防肠道疾病至关重要。虽然转录调控在这一过程中已被公认为关键因素，但翻译调控同样重要。SETD2是一种甲基转移酶，参与转录调控以维持肠道上皮屏障功能。然而，其在翻译调控中的作用仍 largely 未被探索。在本研究中，我们发现SETD2缺失会导致核糖体生物发生过程的下调，并伴随转录组与蛋白质组之间的不一致。进一步的核糖体谱系测序分析显示，在肠上皮屏障受损情况下，细胞黏附和连接相关特征的翻译效率降低。从机制上看，SETD2缺失会导致核糖体生物发生因子的失调与募集异常，从而损伤核糖体蛋白的组成与分布。这种核糖体生物发生与稳态的破坏引发屏障维持基因的翻译紊乱，最终削弱肠道屏障。总体而言，我们的研究揭示了核糖体生物发生与翻译调控在保护肠上皮屏障中的一个先前未被充分认识的作用，并揭示了SETD2在调节核糖体稳态中的一种新功能。

### 第二部分 AI 大师评价

该研究旨在揭示SETD2在肠上皮屏障稳态中的新作用机制。作者通过分子生物学与核糖体组学分析发现，SETD2缺失导致核糖体生物发生受损及转录-翻译失配，从而损害屏障相关基因的翻译效率。研究创新地将SETD2的功能从传统的转录调控拓展至翻译层面，提出核糖体稳态在肠上皮屏障维持中的关键作用。该成果为理解肠道疾病的分子机制提供了新视角，但其在体内调控网络及临床转化价值仍需进一步研究。

---

## 14. 辐照肿瘤细胞来源的微粒通过中性粒细胞内STING/NLRP3/GSDMD轴激活系统性抗肿瘤免疫反应

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486731)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486731
**DOI：** 10.1002/advs.202514390

### 第一部分 原文与翻译

**英文原标题：** Irradiated Tumor Cell-Derived Microparticles Activate Systemic Anti-Tumor Immunity via the STING/NLRP3/GSDMD Axis in Neutrophils.

> **英文摘要：**
> Radiotherapy is known to trigger immunogenic cell death and activate local anti-tumor immune responses. However, its systemic immunomodulatory effects remain poorly understood. Here, we discovered that irradiated tumor cell-derived microparticles (RT-MPs) are released into the circulation and subsequently taken up by neutrophils in the spleen. The mitochondrial DNA contained within RT-MPs promotes the hyperactivation of neutrophils, leading to the secretion of interleukin-1beta (IL-1β) via the STING/NLRP3/GSDMD axis. IL-1β, in turn, enhances the antigen-presenting capacity of dendritic cells (DCs), which facilitates the formation of cytotoxic T lymphocytes (CTLs) in the spleen. These CTLs then contribute to the destruction of distant, non-irradiated tumors. Our findings provide valuable insights into the mechanisms by which radiotherapy can directly modulate systemic anti-tumor immunity, highlighting the potential for leveraging these effects to improve the efficacy of cancer treatment.

> **中文摘要：**
> 放射治疗已知可诱导免疫原性细胞死亡并激活局部抗肿瘤免疫反应。然而，其系统性免疫调节效应仍然了解不足。在本研究中，我们发现辐照肿瘤细胞来源的微粒（RT-MPs）可释放入血液循环，并随后被脾脏中的中性粒细胞摄取。RT-MPs所含的线粒体DNA可促进中性粒细胞的过度激活，并通过STING/NLRP3/GSDMD轴介导白细胞介素-1β（IL-1β）的分泌。而IL-1β反过来增强树突状细胞（DCs）的抗原呈递能力，从而促进脾脏内细胞毒性T淋巴细胞（CTLs）的形成。这些CTLs随后有助于破坏远处未受辐照的肿瘤。我们的研究结果为放射治疗直接调控系统性抗肿瘤免疫的机制提供了重要见解，强调了利用这些效应以提高癌症治疗效果的潜力。

### 第二部分 AI 大师评价

该研究揭示了放射治疗通过肿瘤细胞来源微粒介导系统性抗肿瘤免疫的新机制。作者发现辐照后释放的RT-MPs可被中性粒细胞摄取，激活STING/NLRP3/GSDMD信号轴引发IL-1β分泌，并间接增强树突状细胞与CTL反应，从而靶向远处肿瘤。该发现拓宽了放疗免疫调控的理解，为联合免疫治疗提供了新思路。尽管研究机制深入，但其临床可转化性及不同肿瘤类型间的适用性仍需进一步验证。

---

## 15. PROTAC介导的HMGCR耗竭通过铁死亡重编程乳腺癌脂质代谢以增强光免疫治疗效应

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486701)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486701
**DOI：** 10.1002/advs.202521525

### 第一部分 原文与翻译

**英文原标题：** PROTAC‑Mediated HMGCR Depletion Reprograms Lipid Metabolism in Breast Cancer to Potentiate Photoimmunotherapy via Ferroptosis.

> **英文摘要：**
> Aberrant lipid metabolism characterizes the progression of breast cancer. Statins, the canonical agents for modulating this pathway, have been associated with improved overall survival in patients with triple-negative breast cancer (TNBC). However, their clinical benefit remains limited because the reversible inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) elicits a rebound in the mevalonate pathway and enables evasion of ferroptosis. Therefore, we developed a 170 nm self-assembled nanomedicine (PRO-P) that integrates an HMGCR-targeting PROTAC (PRO) with a disulfide-linked Pyropheophorbide-a (Ppa) photosensitizer, enabling laser-gated protein HMGCR degradation and photodynamic stress within one formulation. Under laser irradiation, PRO-P catalytically depletes HMGCR while generating reactive oxygen species (ROS), collapsing the mevalonate/CoQ10-GPX4 axis and redirecting lipids into ferroptosis. In 4T1 cells, PRO-P enhanced cellular uptake by 1.34-fold and elevated ROS by 9.5-fold. Following intravenous administration in TNBC xenografts, PRO-P achieved 92.5% tumor regression, eradicated pulmonary metastases, and elicited no systemic toxicity after single laser exposure. Immune profiling revealed remodeling of the microenvironment, with 2.6-fold more CD8⁺ Granzyme-B⁺ T cells, 4.3-fold more mature dendritic cells, and fewer Tregs, thereby establishing durable memory. PRO-P exploits multi-omics-guided HMGCR targeting to convert lipid addiction into a redox-immunologic vulnerability, yielding a low-toxicity therapy for TNBC and other lipid-driven cancers.

> **中文摘要：**
> 异常的脂质代谢是乳腺癌进展的特征。作为调节该通路的经典药物，他汀类与三阴性乳腺癌（TNBC）患者总生存率的改善相关。然而，其临床获益有限，因为3-羟基-3-甲基戊二酰辅酶A还原酶（HMGCR）的可逆性抑制会引发甲羟戊酸途径的反弹，并使细胞逃避铁死亡。为此，我们开发了一种170纳米自组装纳米药物（PRO-P），该药物将靶向HMGCR的PROTAC（PRO）与二硫键连接的光敏剂吡光叶绿素a（Ppa）结合在一起，实现了激光控制下的HMGCR蛋白降解和光动力学应激。在激光照射下，PRO-P能够催化性地耗竭HMGCR，同时生成活性氧（ROS），导致甲羟戊酸/辅酶Q10-GPX4轴崩解，并将脂质重定向进入铁死亡途径。在4T1细胞中，PRO-P使细胞摄取提高1.34倍，ROS增加9.5倍。静脉注射至TNBC异种移植瘤后，PRO-P在单次激光照射下实现了92.5%的肿瘤回缩，清除了肺转移灶，且未引起系统性毒性。免疫谱分析显示肿瘤微环境重塑，CD8⁺颗粒酶B⁺T细胞增多2.6倍，成熟树突状细胞增多4.3倍，而调节性T细胞数量减少，从而建立了持久的免疫记忆。PRO-P利用多组学指导的HMGCR靶向策略，将脂质依赖性转化为氧化还原—免疫脆弱性，为TNBC及其他脂质驱动型癌症提供了一种低毒性的治疗新途径。

### 第二部分 AI 大师评价

本研究旨在通过靶向HMGCR的PROTAC纳米药物重编程乳腺癌脂质代谢，以增强铁死亡介导的光免疫治疗效果。研究团队设计的PRO-P系统在光照下可同时实现HMGCR降解与ROS生成，显著抑制TNBC肿瘤生长并诱导免疫活化。实验结果证实其在动物模型中具有高效抗肿瘤作用和良好生物安全性。该策略创新性地将蛋白降解、光动力疗法与铁死亡机制整合，展示了跨学科精准肿瘤治疗的新方向。其潜在局限在于临床光照深度和纳米药物递送的可控性仍需进一步评估。

---

## 16. 通过 PI3K/NF-κB 激活实现的机械刺激诱导的生物打印癌症微组织恶性行为调控

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486700)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486700
**DOI：** 10.1002/advs.202518295

### 第一部分 原文与翻译

**英文原标题：** Mechanical Stimuli-Induced Manipulation of Malignant Behavior in Bioprinted Cancer Microtissues via PI3K/NF-κB Activation.

> **英文摘要：**
> Increased matrix stiffness within tumor microenvironments (TMEs) significantly influences cancer progression and gene expression, contributing to drug resistance and poor clinical outcomes. Studies demonstrate a strong correlation between nuclear factor kappa B (NF-κB) upregulation and prostate cancer malignancy. However, the mechanisms by which the mechanical stress within the TME activates NF-κB remain underexplored. This study developed a prostate cancer spheroid model using an in-bath 3D bioprinting technique. Cancer spheroids were printed within a bespoke hydrogel bath with tunable stiffness, facilitating the investigation of the relationship between mechanical cues and oncogenic behavior. Increased hydrogel stiffness promoted spheroid compaction, induction of epithelial-mesenchymal transition (EMT) and stemness programs, and elevated drug resistance. Transcriptomic analysis revealed that the phosphoinositide 3-kinase (PI3K) pathway is most enriched under mechanical stress. Findings demonstrated that increased extracellular matrix stiffness activated PI3K/NF-κB signaling through mechanotransduction. Pharmacological inhibition of PI3K suppressed NF-κB nuclear translocation and enhanced chemotherapy efficacy. The bespoke hydrogel effectively recapitulated the mechanical environment of prostate cancer, indicating the pivotal role of PI3K/NF-κB signaling in regulating prostate cancer malignancy under mechanical stimulation. This suggests a promising therapeutic avenue for improving treatment outcomes.

> **中文摘要：**
> 肿瘤微环境（TME）中增加的基质刚度显著影响癌症的进展和基因表达，进而导致耐药性增强和临床结局不佳。研究表明，核因子κB（NF-κB）上调与前列腺癌的恶性程度密切相关。然而，TME 内机械应力如何激活 NF-κB 的机制仍未得到充分研究。本研究采用浴内三维生物打印技术建立了一种前列腺癌球体模型。癌球体被打印在具有可调刚度的定制水凝胶浴中，从而便于研究机械信号与致瘤行为之间的关系。结果显示，增加水凝胶的刚度促进了球体的致密化、上皮—间质转化（EMT）及干性程序的诱导，并增强了药物耐受性。转录组分析显示，磷脂酰肌醇3-激酶（PI3K）通路在机械应力下最为富集。研究结果表明，增加的细胞外基质刚度通过机械转导激活了 PI3K/NF-κB 信号通路。药理性抑制 PI3K 可抑制 NF-κB 的核转位，并提高化疗效果。该定制水凝胶有效再现了前列腺癌的机械环境，表明 PI3K/NF-κB 信号通路在机械刺激下调控前列腺癌恶性行为中起关键作用。这提示一种改善治疗结局的潜在治疗新途径。

### 第二部分 AI 大师评价

本研究旨在揭示机械刺激如何通过 PI3K/NF-κB 通路调控前列腺癌的恶性行为。研究者利用浴内三维生物打印技术构建可调刚度的癌症球体模型，系统解析机械应力对细胞表型及信号通路的影响。结果指出，基质硬度升高可激活 PI3K/NF-κB 信号、诱发 EMT 与干性表型，并增强耐药性；而抑制 PI3K 可逆转上述效应并提高化疗敏感性。该研究创新性地模拟肿瘤机械微环境，为机械—信号耦合机制的研究及抗癌治疗策略的优化提供了新思路，但仍需在体模型验证以评估其临床可行性。

---

## 17. 基于氧化还原程序调控的双模态探针用于高保真肿瘤界定与影像引导手术的激活研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486687)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486687
**DOI：** 10.1002/advs.202519223

### 第一部分 原文与翻译

**英文原标题：** Redox-Programmed Activation of a Dual-Modal Probe for High-Fidelity Tumor Delineation and Image-Guided Surgery.

> **英文摘要：**
> The nonspecific activation of activatable probes presents significant challenges in their applications for accurate cancer detection, leading to false signals in normal tissues and the potential oversight of microlesions. To address this issue, we developed a glutathione (GSH)-activatable magnetic resonance imaging (MRI) and near-infrared II (NIR-II) fluorescent probe (GAP9) using a redox capacity engineering strategy. By systematically adjusting the reaction pH during probe synthesis, we could precisely modulate its oxidation capacity to ensure that the activation window of the probe precisely matched tumor GSH concentrations. This strategy ensures that GAP9 remains in the "OFF" state within normal tissues through dual MRI/NIR-II quenching mechanisms, minimizing false-positive signals and background noise. Upon reaching tumor sites, GAP9 undergoes GSH-triggered disassembly, rapidly activating T1-weighted MRI for preoperative tumor mapping and unlocking NIR-II fluorescence for real-time intraoperative tumor delineation. This tumor-adaptable strategy enables the specific localization of microtumor lesions, intraoperative margin monitoring, and complete excision of ultrasmall residual foci ≤1 mm, achieving a 96% detection rate in a mouse model of peritoneal metastasis. This study presents a novel paradigm in molecular probe design, emphasizing the potential of integrating programmable redox chemistry with tumor-specific characteristics to enhance detection accuracy, ultimately improving surgical outcomes and patient prognoses.

> **中文摘要：**
> 可激活探针的非特异性激活在其用于精确癌症检测时带来了重大挑战，导致正常组织中出现假信号，并可能遗漏微小病灶。为解决这一问题，我们采用氧化还原能力工程策略，开发了一种谷胱甘肽（GSH）可激活的磁共振成像（MRI）与近红外II区（NIR-II）荧光双模态探针（GAP9）。通过在探针合成过程中系统调控反应pH，我们能够精确调节其氧化能力，以确保探针的激活窗口与肿瘤中GSH浓度精确匹配。该策略通过双重MRI/NIR-II猝灭机制，使GAP9在正常组织中保持“关闭”状态，从而最大限度减少假阳性信号和背景噪声。当到达肿瘤部位后，GAP9在GSH触发下发生解离，迅速激活T1加权MRI以实现术前肿瘤成图，同时释放NIR-II荧光以实现术中实时肿瘤界定。该肿瘤自适应策略使得微肿瘤病灶的特异性定位、术中切缘监测及≤1 mm超小残留灶的完全切除成为可能，并在腹膜转移小鼠模型中实现了96%的检测率。本研究提出了一种分子探针设计的新范式，强调了将可编程氧化还原化学与肿瘤特异性特征相结合以提高检测准确性的潜力，从而最终改善手术效果和患者预后。

### 第二部分 AI 大师评价

本研究旨在通过氧化还原编程策略，构建一种能够精准响应肿瘤微环境的双模态成像探针，实现高保真度的肿瘤识别与手术引导。文中提出的GSH可激活探针GAP9，兼具MRI和NIR-II双成像能力，能在正常组织中保持静默，在肿瘤部位选择性激活。实验结果显示该探针在微小病灶检测及术中边界识别方面表现优异，显著提高检测准确性。其创新性在于将氧化还原化学与肿瘤特异性代谢环境精确匹配，拓展了分子影像探针的设计理念，但仍需在临床转化与生物安全性方面进一步验证。

---

## 18. 将构象空间与药效团信息引入分子基础模型的学习研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486619)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486619
**DOI：** 10.1002/advs.202513556

### 第一部分 原文与翻译

**英文原标题：** Learned Conformational Space and Pharmacophore Into Molecular Foundational Model.

> **英文摘要：**
> The emergence of large-scale chemical pre-trained models has significantly advanced our ability to capture complex relationships between molecular structures and their functions. Despite the growing interest in molecular foundational model that provide versatile representations and support molecular optimization for downstream tasks, few efforts have integrated explicit chemical knowledge-such as conformational and pharmacophore information-into pre-training. Given the highly dynamic nature of small molecules in solution, their conformational changes upon target binding, and the critical role of pharmacophore complementarity, it is essential to incorporate these factors into molecular foundational modeling. Here, we present a molecular foundational model that integrates conformational-space and pharmacophore-similarity projections during pre-training to regularize the representation space. The model adopts an Ouroboros-like architecture, where the molecular graphs are encoded into 1D representation vectors via a graph neural network and subsequently reconstructed back into SMILES sequences through an autoregressive Transformer module. This dual-module design establishes a flexible and extensible framework for both representation learning and molecular generation within a unified latent space. Extensive experiments demonstrate that our model effectively addresses a variety of practical chemical challenges, including similarity-based virtual screening, targeted poly-pharmacology design, chemical property prediction, and directed molecular optimization.

> **中文摘要：**
> 大型化学预训练模型的出现显著提升了我们捕捉分子结构与其功能之间复杂关系的能力。尽管分子基础模型在提供多样化表示并支持下游任务中的分子优化方面引起了广泛兴趣，但很少有研究在预训练过程中整合显性化学知识——例如构象与药效团信息。鉴于小分子在溶液中的高度动态特性、结合靶标时的构象变化，以及药效团互补性所起的关键作用，将这些因素纳入分子基础建模是至关重要的。本文提出了一种在预训练阶段整合构象空间与药效团相似性投影的分子基础模型，以正则化其表示空间。该模型采用类似“衔尾蛇”的双模块架构：通过图神经网络将分子图编码为一维表示向量，随后经自回归Transformer模块重建为SMILES序列。这一双模块设计在统一的潜在空间中建立了灵活且可扩展的框架，可同时支持表示学习与分子生成。大量实验结果表明，该模型能够有效应对多种实际化学挑战，包括基于相似性的虚拟筛选、靶向多药理设计、化学性质预测以及定向分子优化。

### 第二部分 AI 大师评价

本研究旨在通过将构象空间和药效团信息显式融入预训练阶段，增强分子基础模型的化学知识表达能力。作者提出的“衔尾蛇式”架构结合图神经网络与自回归Transformer，实现了表示学习与分子生成的统一。实验验证模型在多种化学任务中表现优越，凸显其在化学信息学与药物设计交叉领域的创新性。其局限可能在于预训练数据的多样性及准确建模物理化学动态的能力仍需进一步提升。

---

## 19. 通过双重阻断UCP2和IL-17实现T细胞代谢重编程以增强抗胰腺癌免疫力

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486584)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486584
**DOI：** 10.1002/advs.202513020

### 第一部分 原文与翻译

**英文原标题：** Metabolic Reprogramming of T Cells by Dual UCP2 and IL-17 Blockade Enhances Immunity Against Pancreatic Cancer.

> **英文摘要：**
> Pancreatic ductal adenocarcinoma (PDAC) remains resistant to immunotherapy due to its immunosuppressive tumor microenvironment (TME) and impaired metabolic fitness of effector T cells. Here, we show that targeting UCP2 reprograms T-cell metabolism, and that dual blockade with IL-17 further enhance antitumor responses in PDAC. Pharmacologic UCP2 inhibition with genipin increases IFN-γ production by CD8⁺ T cells through IL-12R/STAT4/mTOR signaling and enhanced mitochondrial oxidative phosphorylation, promoting a T-bet-driven cytotoxic program. However, UCP2 inhibition alone does not suppress tumor growth. Accordingly, combination with IL-17 depletion synergistically augments Tc1/Th1 responses, reduces myeloid-derived suppressor cells (MDSCs), and improves survival across multiple PDAC models, including genetically engineered and orthotopic systems. CD8⁺ T-cell depletion abrogates these effects. Moreover, UCP2 inhibition enhances IFN-γ production in patient-derived PBMCs and tumor-infiltrating lymphocytes. These findings identify UCP2 as a metabolic checkpoint in cytotoxic T cells and support dual UCP2/IL-17 blockade as a promising immunotherapeutic strategy for PDAC.

> **中文摘要：**
> 胰腺导管腺癌（PDAC）由于其免疫抑制性肿瘤微环境（TME）以及效应T细胞代谢适能受损，仍然对免疫治疗保持耐受。在本研究中，我们表明靶向UCP2可以重编程T细胞代谢，而与IL-17的双重阻断可进一步增强PDAC的抗肿瘤反应。采用栀子苷（genipin）进行药理性UCP2抑制，可通过IL-12R/STAT4/mTOR信号通路及增强线粒体氧化磷酸化，提高CD8⁺ T细胞的IFN-γ产生，从而促进由T-bet驱动的细胞毒性程序。然而，单纯抑制UCP2并不能抑制肿瘤生长。因此，与IL-17耗竭联合应用可协同增强Tc1/Th1反应，减少髓源性抑制细胞（MDSCs），并在多种PDAC模型（包括基因工程模型及原位模型）中改善生存。CD8⁺ T细胞的耗竭会消除这些效应。此外，UCP2抑制还能增强来源于患者的外周血单个核细胞（PBMCs）及肿瘤浸润淋巴细胞的IFN-γ产生。这些研究结果揭示UCP2是细胞毒性T细胞中的代谢检查点，并支持将双重UCP2/IL-17阻断作为一种有前景的PDAC免疫治疗策略。

### 第二部分 AI 大师评价

该研究旨在通过靶向代谢调控改善胰腺导管腺癌中T细胞的功能活性。作者发现，药理性UCP2抑制能增强T细胞能量代谢与细胞毒性，但单独作用不足以抑制肿瘤，需与IL-17阻断联合，显著提高抗肿瘤免疫反应及生存。结果揭示UCP2作为细胞毒性T细胞的代谢检查点，为通过双重代谢与细胞因子路径联合干预的免疫治疗提供了新思路。研究创新性显著，但仍需进一步验证在人类患者中的安全性与疗效。

---

## 20. BHLHE40 调控效应型组织驻留记忆 CD8 T 细胞并限制肾移植物的长期存活。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486507)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486507
**DOI：** 10.1002/advs.202520518

### 第一部分 原文与翻译

**英文原标题：** BHLHE40 Orchestrates Effector Tissue-Resident Memory CD8 T Cells and Limits Long-Term Survival of Kidney Graft.

> **英文摘要：**
> Tissue-resident memory T cells (T), which function against tumors, infections, and non-self antigens in organ transplantation, exhibit both effector and memory functionality. However, the homeostasis and differentiation of T is not clear. Using a murine kidney transplant model for long-term observation, our single-cell and spatial transcriptomics showed that CD49aPD1 CD8 T exhibited an effector phenotype with enhanced cytotoxicity at a later stage. This subset might mature from a CXCR6 precursor-like state with proliferation capacity in tertiary lymphoid structures (TLSs) in allografts. Mechanically, BHLHE40 is required for CD49aPD1 CD8 T differentiation and effector function, thereby driving rejection in allo-transplantation. In TLSs, TGF-β orchestrated BHLHE40 expression in T and effector T differentiation. Our findings identified an effector subset of T as CD49aPD1 CD8 T, and highlighted a BHLHE40-orchestrated, resident immune component, rather than circulating cells, as a major contributor to allograft rejection.

> **中文摘要：**
> 组织驻留记忆 T 细胞（T）在肿瘤、感染及器官移植中的异体抗原反应中发挥作用，兼具效应与记忆功能。然而，T 细胞的稳态维持及分化过程尚不清楚。通过建立小鼠肾移植长期观察模型，本研究结合单细胞与空间转录组学发现，CD49aPD1 CD8 T 细胞在晚期呈现出效应型表型，并具有增强的细胞毒活性。该亚群可能来源于在异体移植物中三级淋巴结构（TLSs）内具备增殖能力的 CXCR6 前体样状态。机制上，BHLHE40 对 CD49aPD1 CD8 T 细胞分化及效应功能的形成是必需的，从而驱动了异体移植排斥反应。在 TLSs 中，TGF-β 调控 T 细胞中 BHLHE40 的表达及其效应性分化。研究结果鉴定出一种效应型 T 细胞亚群——CD49aPD1 CD8 T，并强调一种由 BHLHE40 协调的组织驻留免疫成分，而非循环细胞，是同种异体移植物排斥反应的主要贡献者。

### 第二部分 AI 大师评价

该研究利用小鼠肾移植长期模型，结合单细胞与空间转录组学，揭示了 BHLHE40 在效应型组织驻留记忆 CD8 T 细胞分化及功能维持中的关键作用。研究发现 CD49aPD1 CD8 T 细胞为主要效应亚群，并受 TGF-β 调控 BHLHE40 表达，从而介导移植排斥。该工作阐明了移植物局部免疫稳态的新机制，为改进移植免疫调控策略提供了重要依据。研究创新性体现在解析局部驻留免疫细胞的驱动机制，但仍需在人类样本中进一步验证。

---

## 21. 工程化细菌囊泡递送乳酸重编程促进肿瘤放疗敏感性。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486457)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486457
**DOI：** 10.1002/advs.202524303

### 第一部分 原文与翻译

**英文原标题：** Engineered Bacteria-Vesicle Delivered Lactate Reprogramming Boosts Tumor Radiosensitivity.

> **英文摘要：**
> Radiotherapy (RT) remains a cornerstone in cancer treatment, yet its efficacy is often compromised by tumor-acquired radioresistance, driven in part by lactate accumulation in the tumor microenvironment (TME). Lactate fosters therapeutic resistance through aberrant DNA repair, immunosuppression, and metabolic reprogramming, posing a formidable clinical challenge. Here, we report a precision microbial therapy leveraging engineered Escherichia coli Nissle 1917 (EcNΔnlpI, ENHL) to target and deplete lactate in the TME. By utilizing engineered bacteria with nlpI gene deletion to enhance outer membrane vesicles (OMVs) biogenesis and introducing a bifunctional surface display system (INP-HlpA for tumor targeting and ClyA-EGFP for tracking), ENHL delivers lactate oxidase (LOx) to neutralize acidic stress. In vitro and in vivo studies confirm that ENHL and LOx-loaded OMVs effectively radiosensitize colorectal cancer cells by depleting tumor-derived and radiation-induced lactate. Oral administration of ENHL selectively colonizes tumors, where arabinose induction triggers localized LOx expression, significantly improving radiosensitivity and immune cell infiltration while modulating gut microbiota. This synergistic approach-combining targeted metabolic modulation with microbial precision therapy-represents a transformative strategy to overcome RT resistance in colorectal cancer, offering a promising pathway toward clinical translation.

> **中文摘要：**
> 放射治疗（RT）仍是癌症治疗的基石，但其疗效常常受到肿瘤获得性放射抗性的限制，而这种抗性部分由肿瘤微环境（TME）中乳酸的积累所驱动。乳酸通过异常的DNA修复、免疫抑制和代谢重编程促进治疗抗性，构成了重大的临床挑战。本研究报道了一种精准的微生物治疗方法，利用工程化大肠杆菌Nissle 1917（EcNΔnlpI，简称ENHL）靶向并消耗TME中的乳酸。通过删除nlpI基因以增强外膜囊泡（OMVs）的生物发生，并引入双功能表面展示系统（INP-HlpA用于肿瘤靶向，ClyA-EGFP用于追踪），ENHL能够递送乳酸氧化酶（LOx）以中和酸性应激。体内外研究证实，ENHL及其负载LOx的OMVs能够通过耗尽肿瘤来源及放射诱导的乳酸，有效增强结直肠癌细胞的放射敏感性。口服给药的ENHL可选择性地定植于肿瘤中，经L-阿拉伯糖诱导后可触发局部LOx表达，显著提高放疗敏感性和免疫细胞浸润，同时调节肠道菌群。这种将靶向代谢调控与微生物精准治疗相结合的协同策略，为克服结直肠癌放疗抗性提供了一种具有变革性意义的新途径，并为临床转化提供了有前景的方向。

### 第二部分 AI 大师评价

本文创新性地提出利用基因工程改造的大肠杆菌递送乳酸氧化酶，以清除肿瘤微环境中促放疗抗性的乳酸，从而增强结直肠癌的放疗敏感性。研究结合了代谢重编程与微生物治疗，通过OMVs传递系统实现了高效的靶向与局部效应。体内外验证数据充分支持该策略提升肿瘤放疗效果及免疫反应的潜力。该工作在微生物辅助放疗领域具有显著创新性，但其长期安全性与临床适用性仍需进一步评估。

---

## 22. 哺乳动物蛋白质组学分析揭示 DNA 链对称与非对称 5-羟甲基胞嘧啶修饰的识读蛋白与反识读蛋白

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486423)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486423
**DOI：** 10.1002/advs.202511925

### 第一部分 原文与翻译

**英文原标题：** Mammalian Proteome Profiling Reveals Readers and Antireaders of Strand-Symmetric and -Asymmetric 5-Hydroxymethylcytosine-Modifications in DNA.

> **英文摘要：**
> The cytosine (C) modifications 5-methylcytosine (mC) and 5-hydroxymethylcytosine (hmC) are central regulatory elements of mammalian genomes. Both marks occur in double-stranded DNA in either strand-symmetric or -asymmetric fashion, but it is still poorly understood how this symmetry information is selectively read out by the nuclear proteome as the basis of potential symmetry-dependent regulation. We report enrichment/proteomics studies with promoter probes being strand-symmetrically or asymmetrically modified with C, mC, and hmC, enabling comparison of their reader profiles in the same sequence, tissue, and experimental contexts. We identify a high number of tissue-specific readers for hmC-modified sequences that fall into distinct, probe-specific sub-groups, including members of important transcription factor classes and chromatin regulators. Among them, we discover the master regulators MYC and MAX that play central roles in cell (de)differentiation and cancer progression to read hmC in a sequence-dependent manner. We also find RFX5, a transcription factor involved in primary MHC class II deficiency, to discriminate between hmC symmetries in CpG dyads. Our findings provide further support for the hypothesis that hmC symmetry information can provide distinct regulatory outputs and provide a resource for studying the molecular mechanisms triggered by symmetric and asymmetric hmC modifications in chromatin regulation during development and disease.

> **中文摘要：**
> 胞嘧啶（C）的修饰形式——5-甲基胞嘧啶（mC）和5-羟甲基胞嘧啶（hmC），是哺乳动物基因组中的关键调控元件。这两种标记都可在双链DNA中以链对称或非对称的方式出现，但关于细胞核蛋白质组如何选择性读取这种对称性信息，从而实现可能的对称性依赖性调控，仍知之甚少。我们报道了采用富集/蛋白质组学方法的研究，利用分别在C、mC和hmC上进行链对称或非对称修饰的启动子探针，在相同的序列、组织及实验条件下比较其识读蛋白谱。我们鉴定出大量针对hmC修饰序列的组织特异性识读蛋白，这些蛋白分属不同的探针特异性亚群，包括多个重要转录因子家族及染色质调控因子。在这些识读蛋白中，我们发现MYC和MAX这两种在细胞（去）分化及癌症进展中发挥核心作用的主调控因子，能以序列依赖的方式识读hmC。同时，我们还发现与原发性MHC II类缺陷相关的转录因子RFX5，能够区分CpG二聚体中hmC修饰的对称性。我们的发现进一步支持了这样一种假设：hmC的对称性信息可产生不同的调控输出，并为研究发育与疾病中由对称或非对称hmC修饰触发的染色质调控分子机制提供了重要资源。

### 第二部分 AI 大师评价

该研究聚焦于DNA中5-羟甲基胞嘧啶修饰的链对称性识读机制，利用富集与蛋白质组学方法构建了不同修饰方式的启动子探针，从蛋白质组层面系统比较其识读蛋白谱。结果揭示了多个组织特异性的识读因子，特别是发现MYC、MAX及RFX5等关键转录调控因子可对hmC序列与对称性进行差异识别。这一工作创新性地揭示了hmC对称性在染色质调控中的潜在功能，为理解发育与疾病相关的表观遗传调控提供了重要线索。研究主要局限于体外实验，后续有必要在细胞与动物水平验证其生物学意义。

---

## 23. USP35 作为 ID3 的去泛素化酶促进结直肠癌免疫逃逸

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486422)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486422
**DOI：** 10.1002/advs.202516588

### 第一部分 原文与翻译

**英文原标题：** USP35 Acts as a Deubiquitinating Enzyme for ID3 to Promote Immune Escape in Colorectal Cancer.

> **英文摘要：**
> Our prior investigation has demonstrated that ID3 modulates PD-L1, thereby affecting immune evasion in colorectal cancer (CRC). Nonetheless, the regulatory mechanisms of ID3, particularly those involving its ubiquitination and degradation, remain inadequately understood. In this study, we identify USP35 as a deubiquitinating enzyme for ID3, which stabilizes ID3 by targeting the N-terminal lysine residues K2 and K30, thus inhibiting its ubiquitination and degradation. This stabilization enhances ID3's transcriptional activity, resulting in elevated PD-L1 expression in CRC and facilitating immune escape. Furthermore, we discover an effective inhibitor of USP35 enzyme activity, IU1, which directly suppresses ID3 expression by promoting its ubiquitination and subsequently reducing PD-L1 expression. IU1 not only impedes tumor cell proliferation, but also augments the efficacy of PD-L1 monoclonal antibody therapy by enhancing anti-tumor immune responses. These findings elucidate a novel mechanism by which the USP35-ID3-PD-L1 axis contributes to immune evasion in CRC and propose a potential therapeutic strategy to improve the efficacy of immunotherapy in CRC patients.

> **中文摘要：**
> 我们先前的研究表明，ID3 可调控 PD-L1，从而影响结直肠癌（CRC）的免疫逃逸。然而，关于 ID3 的调控机制，尤其涉及其泛素化和降解的过程，仍缺乏充分理解。本研究鉴定出 USP35 是 ID3 的去泛素化酶，其通过靶向 ID3 的 N 端赖氨酸残基 K2 和 K30 来稳定 ID3，从而抑制其泛素化与降解。这种稳定作用增强了 ID3 的转录活性，导致 CRC 中 PD-L1 表达升高并促进免疫逃逸。此外，我们发现 USP35 酶活性的有效抑制剂 IU1，可通过促进 ID3 的泛素化直接抑制其表达，从而下调 PD-L1。IU1 不仅能抑制肿瘤细胞的增殖，还能通过增强抗肿瘤免疫反应提高 PD-L1 单克隆抗体治疗的疗效。这些发现阐明了 USP35–ID3–PD-L1 轴参与 CRC 免疫逃逸的新机制，并提出了一种可用于改善结直肠癌免疫治疗疗效的潜在治疗策略。

### 第二部分 AI 大师评价

本文揭示 USP35 通过去泛素化作用稳定 ID3，从而上调 PD-L1 并促进结直肠癌的免疫逃逸。研究进一步发现 USP35 抑制剂 IU1 能加速 ID3 泛素化、降低 PD-L1 表达，并增强免疫治疗效果。该工作在机制层面明确了 USP35–ID3–PD-L1 轴的作用，为 CRC 免疫治疗提供了新的干预靶点。尽管结果具有潜在临床价值，但仍需在体内模型和临床前验证中进一步确证其安全性和有效性。

---

## 24. 肿瘤浸润性淋巴细胞的单细胞解析揭示了可预测肢端黑色素瘤治疗效应的细胞结构。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486415)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486415
**DOI：** 10.1002/advs.202521555

### 第一部分 原文与翻译

**英文原标题：** Single-Cell Dissection of Tumor-Infiltrating Lymphocytes Reveals Cellular Architecture Predictive of Therapeutic Efficacy in Acral Melanoma.

> **英文摘要：**
> Acral melanoma (AM), the predominant melanoma subtype in Asia, responds poorly to immune checkpoint inhibitors, representing a critical unmet medical need. The efficacy of tumor-infiltrating lymphocyte (TIL) therapy in this population is unknown. An Investigator-Initiated Trial evaluates autologous TIL therapy (LM-103) in four Chinese patients with advanced AM, achieving a 75% disease control rate (DCR) and a 25% objective response rate (ORR), including one durable complete response. To define the determinants of response, we performed integrated single-cell RNA and T-cell receptor sequencing on infused TIL products, tumors, and longitudinal peripheral blood. Responders' infused products were significantly enriched for T follicular helper (Tfh) and intermediate exhausted (TEX_int) CD8⁺ T cells, which mediated robust cell-cell signaling networks (e.g., CD40, FASLG). In contrast, the non-responder's product was dominated by terminally exhausted (TEX_term) cells. Clonal tracking revealed that these Tfh and TEX_int subsets possessed higher clonality, and in the complete responder, a dominant clone originating from the TEX_int population persisted systemically by differentiating into a progenitor-like (TEX_prog) state. These findings demonstrate that TIL therapy is clinically active in AM and that durable response is mechanistically linked to the infusion and persistence of Tfh and TEX_int subsets, defining a key cellular and clonal architecture for therapeutic success.

> **中文摘要：**
> 肢端黑色素瘤（AM）是亚洲最常见的黑色素瘤亚型，对免疫检查点抑制剂反应不佳，构成了一个亟待满足的临床需求。目前尚不清楚肿瘤浸润性淋巴细胞（TIL）治疗在该人群中的疗效。一项研究者发起的临床试验在4例中国晚期AM患者中评估了自体TIL治疗（LM-103），达到了75%的疾病控制率（DCR）和25%的客观缓解率（ORR），其中包括1例持久的完全缓解。为阐明疗效应答的决定因素，我们对输注的TIL制品、肿瘤样本及纵向外周血进行了单细胞RNA测序及T细胞受体测序整合分析。应答者的输注制品中富集了滤泡辅助性T细胞（Tfh）和中度耗竭的（TEX_int）CD8⁺ T细胞，这些细胞介导了强大的细胞-细胞信号网络（如CD40、FASLG）。相反，未应答者的制品主要由末期耗竭（TEX_term）细胞主导。克隆追踪显示，这些Tfh和TEX_int亚群具有更高的克隆性，而在完全应答者中，源自TEX_int群体的一个主要克隆通过分化为具有始祖样特征的（TEX_prog）状态在全身持续存在。这些发现表明，TIL疗法在AM中具有临床活性，且持久应答在机制上与Tfh和TEX_int亚群的输注及持续存在密切相关，从而界定了治疗成功的关键细胞和克隆结构。

### 第二部分 AI 大师评价

本研究针对免疫治疗反应不佳的肢端黑色素瘤开展了自体肿瘤浸润性淋巴细胞临床试验，并结合单细胞组学揭示疗效相关的免疫细胞结构。研究发现，Tfh与中度耗竭CD8⁺ T细胞的富集与持久疗效密切相关，而末期耗竭细胞则与无反应相关。该工作创新性地将临床疗效与单细胞克隆动力学联系起来，为个体化细胞治疗提供了细胞学基础。局限在于样本量较小，仍需更大规模研究验证。

---

## 25. SAGE：用于空间转录组学中空间域识别的空间感知基因选择与双视图嵌入融合方法

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486374)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486374
**DOI：** 10.1002/advs.202520333

### 第一部分 原文与翻译

**英文原标题：** SAGE: Spatially Aware Gene Selection and Dual-View Embedding Fusion for Domain Identification in Spatial Transcriptomics.

> **英文摘要：**
> Despite enabling high-resolution mapping of gene expression within tissues, spatial transcriptomics (ST) still faces challenges in accurately segmenting spatial domains due to complex tissue architecture and limitations of current methods. Most approaches rely on local spatial priors, lack gene-level interpretability, and fall short in capturing structure-discriminative genes or long-range functional relationships, limiting their ability to resolve biologically meaningful architectures. We present Spatially Aware Gene selection and dual-view Embedding fusion (SAGE), a unified and reproducible framework for domain identification in spatial transcriptomics that combines topic-driven gene selection with dual-view embedding fusion to address these gaps. SAGE integrates non-negative matrix factorization (NMF)-based topic modeling with classifier-based importance scoring to identify highly spatially informative genes, and fuses a local expression graph with a topic-driven non-local graph via consensus refinement and contrastive graph representation learning to jointly learn spatial and functional embeddings. Evaluated on 34 real-world datasets, SAGE not only outperforms existing methods in clustering accuracy but also reveals functionally coherent regions and interpretable gene expression patterns. In case studies, SAGE reveals spatial heterogeneity associated with a pre-malignant activation state in human breast cancer. Moreover, in zebrafish melanoma, it refines the tumor-muscle interface into transcriptionally distinct subdomains and uncovers shared vascular signatures between anatomically separate tissues. Together, these results demonstrate that SAGE can be used not only for accurate spatial domain delineation across diverse ST platforms, but also for dissecting microenvironmental niches and long-range tissue interactions underlying disease progression.

> **中文摘要：**
> 尽管空间转录组学（ST）技术能够在组织内实现高分辨率的基因表达图谱绘制，但由于组织结构的复杂性以及现有方法的局限性，其在精确划分空间域方面仍面临挑战。大多数方法依赖局部空间先验，缺乏基因层面的可解释性，且难以捕捉结构判别性基因或远程功能联系，限制了其解析具有生物学意义的组织结构的能力。本文提出了空间感知基因选择与双视图嵌入融合框架（SAGE），一个统一且可复现的空间转录组学空间域识别方法框架，通过结合基于主题的基因选择与双视图嵌入融合以弥补上述不足。SAGE 整合了基于非负矩阵分解（NMF）的主题建模与基于分类器的重要度评分，以识别具有高空间信息价值的基因，并通过共识优化与对比图表示学习，将局部表达图与基于主题驱动的非局部图进行融合，从而联合学习空间与功能嵌入。基于34个真实数据集的评估结果表明，SAGE不仅在聚类精度上优于现有方法，还揭示了功能一致的区域以及可解释的基因表达模式。在案例研究中，SAGE 揭示了与人类乳腺癌前恶变激活状态相关的空间异质性。此外，在斑马鱼黑色素瘤模型中，它进一步细化了肿瘤—肌肉界面为转录上不同的子区域，并发现了不同解剖结构组织间共享的血管特征。综上所述，这些结果表明，SAGE 不仅可用于多种空间转录组平台下的精确空间域划分，也可用于解析疾病进展中潜在的微环境生态位和长程组织交互。

### 第二部分 AI 大师评价

该研究旨在解决空间转录组学中精确划分空间域的难题，开发了名为 SAGE 的新框架，融合了主题驱动基因选择与双视图嵌入学习。通过结合 NMF 主题建模与分类器重要度评分，并整合局部与非局部图的多层信息，SAGE 实现了空间与功能特征的联合建模。实验表明其在34个数据集上优于现有方法，并揭示了乳腺癌和斑马鱼黑色素瘤中的生物学异质性。该方法的创新在于结合空间和功能两种视角的融合学习，但其对超参数与数据噪音的鲁棒性仍可能是进一步优化的方向。

---

## 26. 通过靶向IL27RA调控肿瘤细胞及肿瘤微环境以增强三阴性乳腺癌的免疫治疗效果

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486362)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486362
**DOI：** 10.1002/advs.202516703

### 第一部分 原文与翻译

**英文原标题：** Targeting IL27RA Enhances Immunotherapy in Triple-Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment.

> **英文摘要：**
> Immune checkpoint blockade (ICB) has improved outcomes for patients with triple-negative breast cancer (TNBC), yet resistance remains widespread and its molecular basis is not fully understood. Through single-cell RNA sequencing (scRNA-seq) of paired pre- and post-treatment tumor samples from patients who failed to achieve pathological complete response (non-pCR) after neoadjuvant PD-1 therapy, we identified a marked upregulation of interleukin-27 receptor subunit alpha (IL27RA) in malignant epithelial cells within residual lesions. Integration with scRNA-seq profiles from an independent cohort of three pCR patients showed that this IL27RA upregulation in malignant epithelium is largely restricted to non-pCR residual tumors, and high IL27RA expression correlated with poor survival in TNBC cohorts. Mechanistically, IL27RA suppresses MHC-I expression by activating the PI3K/AKT pathway-rather than the classical IL-27/STAT axis-thereby impairing CD8⁺ T-cell cytotoxic function. Inhibition of AKT reversed this phenotype and restored antigen-specific killing. In orthotopic tumor models, mimicking systemic loss of Il27ra significantly reduced tumor growth and prolonged survival in immunocompetent mice, with single-cell profiling indicating enhanced intratumoral T-cell and NK-cell effector activity. Collectively, our findings identify an epithelial-intrinsic IL27RA-PI3K/AKT-MHC-I axis as a central driver of immune evasion and ICB resistance in TNBC and support IL27RA as a promising therapeutic target for overcoming immunotherapy resistance.

> **中文摘要：**
> 免疫检查点阻断（ICB）已改善三阴性乳腺癌（TNBC）患者的治疗结局，但耐药现象仍然普遍，其分子基础尚未完全阐明。通过对经PD-1新辅助治疗后未能达到病理完全缓解（non-pCR）的患者配对治疗前后肿瘤标本进行单细胞RNA测序（scRNA-seq），我们发现残余病灶中的恶性上皮细胞中白细胞介素-27受体α亚单位（IL27RA）显著上调。结合来自三位pCR患者的独立队列scRNA-seq数据分析显示，IL27RA在恶性上皮中的上调主要限于non-pCR残余肿瘤，并且高IL27RA表达与TNBC患者的不良生存率相关。机制上，IL27RA通过激活PI3K/AKT通路，而非经典的IL-27/STAT通路，抑制MHC-I的表达，从而削弱CD8⁺T细胞的细胞毒活性。抑制AKT可逆转这一表型并恢复抗原特异性杀伤功能。在正位肿瘤模型中，模拟系统性Il27ra缺失显著抑制肿瘤生长并延长免疫健全小鼠的生存期，单细胞分析显示肿瘤内T细胞和NK细胞效应活性增强。综上所述，本研究鉴定出一个上皮内在的IL27RA-PI3K/AKT-MHC-I轴作为TNBC免疫逃逸和ICB耐药的关键驱动因素，并支持IL27RA作为克服免疫治疗耐药的潜在治疗靶点。

### 第二部分 AI 大师评价

本研究聚焦于三阴性乳腺癌免疫治疗耐药机制，结合单细胞转录组学揭示IL27RA在非病理完全缓解肿瘤细胞中的特异性上调及其与不良预后相关。研究通过分子机制解析发现，IL27RA通过PI3K/AKT通路抑制MHC-I表达，从而削弱CD8⁺T细胞功能。动物实验进一步验证了靶向IL27RA可增强抗肿瘤免疫效应并延长生存。该工作提出了IL27RA为潜在免疫治疗新靶点的创新观点，但仍需更多临床研究验证其安全性与疗效。

---

## 27. 全氟辛酸暴露导致巨噬细胞氨滞留并诱发自然流产

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486358)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486358
**DOI：** 10.1002/advs.202506994

### 第一部分 原文与翻译

**英文原标题：** Perfluorooctanoic Acid Exposure Causes Macrophage Ammonia Retention and Induces Spontaneous Miscarriages.

> **英文摘要：**
> Spontaneous miscarriage, the most prevalent complication of early pregnancy, poses substantial risks to maternal health worldwide. Perfluorooctanoic acid (PFOA) is a ubiquitous environmental persistent organic pollutant. Human epidemiological studies have linked PFOA exposure to spontaneous miscarriages, yet the underlying mechanisms have been rarely explored. In this study, we found PFOA exposure induced embryonic absorption in pregnant mice by causing ammonia retention in macrophages. Excessive ammonia disrupted mitochondrial function and compromised lysosomal integrity, which ultimately impaired macrophage function. Furthermore, lysosomal dysfunction reduced secretion of cathepsin B (CTSB) and led to decreased macrophage infiltration and diminished trophoblast invasion. Mechanistically, PFOA exposure led to macrophages ammonia retention by promoting the glutaminolysis through the upregulation of glutaminase (GLS) expression. By downregulating the inhibitor of DNA binding protein 3 (ID3), PFOA enhanced nuclear translocation and DNA-binding affinity of transcription factor 12 (TCF12), which directly activated glutaminase (GLS) transcription to fuel glutamine catabolism. Collectively, our findings delineated a previously unrecognized pathway linking environmental PFOA exposure to spontaneous miscarriage via ammonia-driven macrophage impairment.

> **中文摘要：**
> 自然流产是早孕期最常见的并发症之一，对全球孕产妇健康构成重大风险。全氟辛酸（PFOA）是一种广泛存在的环境持久性有机污染物。流行病学研究已将 PFOA 暴露与自然流产联系起来，但其潜在机制鲜有探讨。在本研究中，我们发现，PFOA 暴露通过引起巨噬细胞的氨滞留，诱导妊娠小鼠发生胚胎吸收。过量的氨破坏了线粒体功能并损害溶酶体完整性，最终削弱了巨噬细胞功能。此外，溶酶体功能障碍降低了组织蛋白酶 B（CTSB）的分泌，导致巨噬细胞浸润减少及滋养层细胞侵袭能力下降。在机制层面，PFOA 暴露通过上调谷氨酰胺酶（GLS）表达，促进谷氨酰胺分解代谢，从而导致巨噬细胞氨滞留。PFOA 通过下调 DNA 结合抑制蛋白 3（ID3），增强了转录因子 12（TCF12）的核转位及其 DNA 结合能力，从而直接激活谷氨酰胺酶（GLS）转录以推动谷氨酰胺分解。综合而言，本研究揭示了一条此前未被认识的径路，即环境性 PFOA 暴露通过氨驱动的巨噬细胞功能受损而导致自然流产。

### 第二部分 AI 大师评价

本研究聚焦于全氟辛酸（PFOA）与自然流产之间的联系，通过动物实验揭示其分子机制。研究发现 PFOA 可引起巨噬细胞氨滞留，进而破坏线粒体与溶酶体功能，阻碍巨噬细胞活性及滋养层细胞侵袭。机制上，PFOA 通过 ID3–TCF12–GLS 途径调控谷氨酰胺代谢，最终导致妊娠失败。该研究创新性地将环境污染物与免疫代谢重塑联系起来，为理解环境毒物导致早孕流产提供了新视角，但其人体相关性尚需进一步验证。

---

## 28. 靶向NOTCH3以清除静息和耐药的多发性骨髓瘤细胞

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486357)
**期刊：** Journal of experimental & clinical cancer research : CR
**PMID：** 41486357
**DOI：** 10.1186/s13046-025-03630-1

### 第一部分 原文与翻译

**英文原标题：** Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells.

> **英文摘要：**
> BACKGROUND: Despite significant therapeutic advances, multiple myeloma (MM) remains incurable in most patients due to frequent tumor relapse. A major contributor to relapse is clonal heterogeneity, where subclones exhibit distinct mechanisms of therapy resistance, along with the presence of drug-resistant dormant cells. Eliminating these distinct populations, which often coexist in the tumor niche, is clinically challenging. Identifying survival mechanisms shared by drug-resistant proliferating and dormant cells holds potential for the simultaneous elimination of different tumor-repopulating clones.
> 
> METHODS: To identify shared mechanisms of therapeutic resistance, we analyzed clinical databases and drug-resistant myeloma cell lines. We employed pharmacologic approaches to target common candidates identified in our analysis and assessed their impact on tumor progression and survival in preclinical mouse models containing both therapy-resistant and dormant cells.
> 
> RESULTS: We identified upregulation of several components of the Notch signaling pathway in both dormant and drug-resistant MM cells, which correlated with poor clinical outcomes in newly diagnosed MM patients. Selective blockade of NOTCH3 with a neutralizing antibody or pan-Notch inhibition with a bone-targeted inhibitor reduced tumor burden and eliminated coexisting dormant and bortezomib-resistant cells in clinically relevant models of MM disease.
> 
> CONCLUSIONS: Our findings reveal that NOTCH3-dependent survival programs represent a shared vulnerability in both cells refractory to therapy and dormant cells. These programs can be exploited to overcome the diverse mechanisms by which cancer cells evade therapy, potentially preventing disease relapse and extending remission in patients with MM.

> **中文摘要：**
> 背景：尽管治疗手段取得了显著进展，但多数多发性骨髓瘤（MM）患者仍难以治愈，主要原因是肿瘤频繁复发。复发的重要原因之一是克隆异质性，其中不同亚克隆表现出不同的耐药机制，同时还存在耐药的静息细胞。清除这些在肿瘤微环境中共存的不同细胞群体在临床上极具挑战。识别耐药增殖细胞和静息细胞共享的生存机制，具有同时消除多种能重新形成肿瘤的克隆的潜力。
> 
> 方法：为鉴定共同的治疗耐受机制，我们分析了临床数据库和耐药的骨髓瘤细胞系。我们采用药理学手段靶向分析中识别的共有候选分子，并在含有耐药和静息细胞的临床相关小鼠模型中评估其对肿瘤进展和生存的影响。
> 
> 结果：我们发现，在静息细胞和耐药的MM细胞中，Notch信号通路的多个组分均呈上调，这与新诊断MM患者的不良临床预后相关。利用中和抗体特异性阻断NOTCH3，或采用骨靶向的广谱Notch抑制剂，可降低肿瘤负担，并在临床相关的MM模型中清除共存的静息和硼替佐米耐药细胞。
> 
> 结论：我们的研究发现，依赖NOTCH3的生存程序是治疗难治细胞和静息细胞的共同脆弱点。利用这些机制有望克服癌细胞逃避治疗的多种方式，从而可能预防疾病复发并延长MM患者的缓解期。

### 第二部分 AI 大师评价

该研究旨在通过靶向NOTCH3通路探索多发性骨髓瘤中静息和耐药细胞的共同弱点。作者通过数据库分析、耐药细胞系研究及小鼠模型验证，发现NOTCH3在不同类型的耐药细胞中共同上调，并与不良预后相关。阻断NOTCH3信号可同步清除静息和耐药细胞，减少肿瘤负担。研究揭示了NOTCH3依赖的共性生存机制，为克服耐药与防止复发提供新的治疗策略。然而，未来仍需评估长期安全性及临床转化可行性。

---

## 29. PD-1通过抑制JAML抑止CD4+组织驻留记忆T细胞介导的cDC1动员于人非小细胞肺癌中。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486351)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486351
**DOI：** 10.1002/advs.202507647

### 第一部分 原文与翻译

**英文原标题：** PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.

> **英文摘要：**
> Tissue-resident memory CD4+ T cells (CD4+ TRMs) are pivotal in immune responses during inflammation and infection, yet their phenotype and function within the tumor microenvironment (TME) remain elusive. Here, we delineated CD4+ TRMs in non-small cell lung cancer (NSCLC) using CD103 and CD69 as defining markers and demonstrated that their transcriptional and phenotypic profiles closely resembled those observed in murine models. Tumor-infiltrating CD4+ TRMs exert helper antitumor effects by secreting the chemokine XCL1 to recruit conventional type 1 dendritic cells (cDC1s), facilitating antigen presentation and priming cytotoxic T lymphocyte responses. Mechanistically, we identified the costimulatory molecule JAML as essential for CD4+ TRM-mediated cDC1 mobilization. Compared with their counterparts in normal lung tissue, tumor-infiltrating CD4+ TRMs exhibited elevated expression of immune checkpoint molecules, indicating a dysfunctional state, accompanied by significantly reduced XCL1 expression. PD-1 signaling within the NSCLC TME suppressed JAML expression-an effect reversible by PD-1 blockade-while the administration of a JAML agonist further enhanced the antitumor efficacy of PD-1 inhibitors in tumor-bearing mice. Clinically, the presence of XCL1-secreting CD4+ TRMs positively correlated with favorable clinical outcomes and enhanced responses to anti-PD-1 immunotherapy in NSCLC patients. Our findings reveal a critical role for JAML in facilitating CD4+ TRM-mediated cDC1 mobilization within the NSCLC TME and highlight the translational potential of targeting CD4+ TRMs to enhance the efficacy of immune checkpoint blockade therapies.

> **中文摘要：**
> 组织驻留记忆CD4+ T细胞（CD4+ TRM）在炎症和感染过程中对免疫应答起关键作用，但其在肿瘤微环境（TME）中的表型和功能仍不明确。在本研究中，我们使用CD103和CD69作为定义标志物，在非小细胞肺癌（NSCLC）中描绘了CD4+ TRM，并证明其转录和表型特征与小鼠模型中观察到的高度相似。肿瘤浸润的CD4+ TRM通过分泌趋化因子XCL1招募常规1型树突状细胞（cDC1），从而促进抗原呈递并启动细胞毒性T淋巴细胞反应，发挥辅助抗肿瘤作用。从机制上看，我们确定了共刺激分子JAML对于CD4+ TRM介导的cDC1动员至关重要。与正常肺组织中的对应细胞相比，肿瘤浸润的CD4+ TRM表现出免疫检查点分子表达升高，提示其处于功能失调状态，并伴随XCL1表达显著下降。在NSCLC肿瘤微环境中，PD-1信号抑制了JAML的表达——这一作用可通过PD-1阻断逆转——而施用JAML激动剂进一步增强了PD-1抑制剂在荷瘤小鼠中的抗肿瘤效应。在临床上，分泌XCL1的CD4+ TRM的存在与较好的临床结局及NSCLC患者对抗PD-1免疫治疗的增强反应呈正相关。我们的研究结果揭示了JAML在促进CD4+ TRM介导的cDC1动员中的关键作用，并强调了以CD4+ TRM为靶点以提升免疫检查点抑制疗法疗效的转化潜力。

### 第二部分 AI 大师评价

本研究探讨了非小细胞肺癌中CD4+组织驻留记忆T细胞的表型及功能，揭示PD-1信号通过抑制JAML从而限制了其募集cDC1的能力。研究结合转录组分析、功能实验及动物模型验证，明确了JAML在CD4+ TRM介导抗肿瘤免疫中的核心作用。作者进一步指出，阻断PD-1信号或激活JAML均可增强免疫检查点治疗的疗效。这一发现为改善肺癌免疫治疗反应提供了潜在的新策略，但在不同患者群体中的普适性和长期安全性仍需进一步验证。

---

## 30. 免疫球蛋白重链状态与基质相互作用共同调控慢性淋巴细胞白血病的铁死亡敏感性

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486278)
**期刊：** Signal transduction and targeted therapy
**PMID：** 41486278
**DOI：** 10.1038/s41392-025-02535-x

### 第一部分 原文与翻译

**英文原标题：** Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemia.

> **英文摘要：**
> Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of clonal B cells. Although targeted therapies have improved outcomes, resistance remains a challenge, particularly in high-risk patients with TP53 mutations or unmutated immunoglobulin heavy-chain variable region (IGHV) genes (U-CLL). Ferroptosis, a regulated, iron-dependent form of cell death, may represent an exploitable vulnerability in CLL; however, its mechanisms and clinical relevance remain poorly understood. Here, we identified IGHV status and microenvironmental cues as determinants of ferroptosis sensitivity. Using CLL cell lines, patient samples, and in vivo models, we show that CLL cells exhibit elevated basal levels of lipid peroxides and labile iron, predisposing them to ferroptosis. However, stromal interactions enhance cystine import and glutathione synthesis, thereby mitigating susceptibility to ferroptosis. Mechanistically, BTK inhibition sensitizes CLL cells to ferroptosis by increasing the transferrin receptor (TFRC, CD71) and increasing the intracellular Fe²⁺ level. High TFRC expression was associated with improved survival in two independent CLL patient cohorts, supporting its therapeutic and prognostic relevance. Combining ibrutinib with the GPX4 inhibitor RSL3 enhances ferroptosis and improves antileukemic efficacy in vivo. CLL cells with mutated IGHV genes (M-CLL) display greater TFRC expression and ferroptosis sensitivity than U-CLL cells do. This resistance can be overcome by ibrutinib-mediated TFRC induction or via metabolic targeting of fatty acid metabolism. Notably, ACSL1 is selectively upregulated in U-CLL cells and represents a targetable metabolic enhancer of ferroptosis sensitivity, as shown in vivo. Our findings reveal that TFRC and ACSL1 are functionally distinct yet targetable nodes that govern ferroptosis vulnerability in CLL patients and may guide novel therapeutic strategies for high-risk patients.

> **中文摘要：**
> 慢性淋巴细胞白血病（CLL）的特征是克隆性B细胞的积聚。尽管靶向治疗已改善预后，但耐药性仍然是一个挑战，尤其是在携带TP53突变或免疫球蛋白重链可变区（IGHV）基因未突变（U-CLL）的高风险患者中。铁死亡是一种受调控的、依赖铁的细胞死亡形式，可能代表CLL中可利用的脆弱性；然而，其机制和临床意义仍然了解不足。在本研究中，我们确定了IGHV状态和微环境信号是铁死亡敏感性的决定因素。通过使用CLL细胞系、患者样本及体内模型，我们显示CLL细胞表现出较高的基础脂质过氧化物和游离铁水平，使其易于发生铁死亡。然而，基质相互作用可增强半胱氨酸导入和谷胱甘肽合成，从而减轻对铁死亡的易感性。在机制上，BTK抑制通过上调转铁蛋白受体（TFRC，CD71）并增加细胞内Fe²⁺水平，使CLL细胞对铁死亡更为敏感。在两个独立的CLL患者队列中，高TFRC表达与更好的生存相关，支持其治疗及预后意义。将伊布替尼与GPX4抑制剂RSL3联合使用可增强铁死亡并改善体内抗白血病疗效。携带IGHV突变的CLL细胞（M-CLL）相比U-CLL细胞表现出更高的TFRC表达和铁死亡敏感性。这种耐受性可通过伊布替尼介导的TFRC诱导或通过针对脂肪酸代谢的代谢策略加以克服。值得注意的是，ACSL1在U-CLL细胞中选择性上调，并在体内被证明是促进铁死亡敏感性的可靶向代谢调控因子。我们的研究结果揭示TFRC和ACSL1是功能上不同但可靶向的关键节点，决定CLL患者的铁死亡易感性，并可为高风险患者提供新的治疗策略指导。

### 第二部分 AI 大师评价

本研究揭示了免疫球蛋白重链状态和肿瘤微环境在调控CLL铁死亡敏感性中的关键作用。作者通过体内外实验综合分析，发现BTK抑制和转铁蛋白受体（TFRC）的升高可增强铁死亡反应，而基质细胞通过调节半胱氨酸与谷胱甘肽代谢降低易感性。进一步鉴定ACSL1为U-CLL特异性上调的代谢调控因子，可作为新的治疗靶点。该研究创新性地将铁死亡机制与CLL遗传与代谢特征联系起来，为高风险CLL患者提供潜在的联合治疗策略，但仍需临床验证其安全性与疗效。

---

## 31. 多组学分析揭示在慢性阻塞性肺疾病中，胆固醇驱动的巨噬细胞代谢重编程及其炎症反应。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486269)
**期刊：** Genome medicine
**PMID：** 41486269
**DOI：** 10.1186/s13073-025-01591-w

### 第一部分 原文与翻译

**英文原标题：** Multi-omics reveals cholesterol-driven macrophage metabolic reprogramming and inflammation in chronic obstructive pulmonary disease.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要可用。

### 第二部分 AI 大师评价

该研究利用多组学策略，系统揭示了慢性阻塞性肺疾病中胆固醇代谢异常如何重塑巨噬细胞代谢途径并诱发炎症反应。此发现深化了对COPD炎症机制的分子层面理解，并为靶向代谢通路以缓解疾病提供了新思路。尽管目前具体机制细节及临床转化价值仍需进一步验证，但研究在免疫代谢方向上具有明显的创新性。

---

## 32. 应激程序化免疫生态位促进TNFR2+调节性T细胞活化并驱动乳腺癌新辅助化疗耐药

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486103)
**期刊：** Advanced science (Weinheim, Baden-Wurttemberg, Germany)
**PMID：** 41486103
**DOI：** 10.1002/advs.202512952

### 第一部分 原文与翻译

**英文原标题：** Stress-Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast Cance.

> **英文摘要：**
> The tumor microenvironment (TME) harbors diverse immune cell states that shape therapeutic outcomes in breast cancer. Here, we identify a conserved stress-programmed cellular module as a key responder to neoadjuvant therapies in breast cancer, characterized by coordinated heat shock gene expression across multiple immune cells, based on single-cell transcriptomic data from neoadjuvant chemotherapy-treated patients. We discover that this multicellular program enhances the effector fate of regulatory T cells (Tregs) via chronic and TME-wide TNFα signaling, compromising the efficacy of neoadjuvant chemotherapy. TNFα signaling, typically considered an antitumor cytokine, is paradoxically elevated in nonresponders both pre- and post-treatment, with a particularly prominent TNFα-TNFR2 interaction. Blocking this axis, with or without chemotherapy, significantly suppresses tumor growth without observable toxicities. Our findings highlight the immune-editing role of stress-programmed Effector regulatory T cells, Neoadjuvant chemotherapy, Stress-programmed immune states, TNF α -TNFR2 axis, breast cancercell states and support their therapeutic potential as a rational target in breast cancer.

> **中文摘要：**
> 肿瘤微环境（TME）中存在多种免疫细胞状态，这些状态共同塑造了乳腺癌的治疗结局。本研究基于接受新辅助化疗患者的单细胞转录组数据，鉴定出一个保守的应激程序化细胞模块，作为乳腺癌中新辅助治疗的关键应答者，其特征是在多种免疫细胞中表现出协调的热休克基因表达。我们发现，该多细胞程序通过持续的、整个TME范围内的TNFα信号传导，增强了调节性T细胞（Tregs）的效应命运，从而削弱了新辅助化疗的疗效。通常被视为抗肿瘤细胞因子的TNFα信号在治疗反应不佳的患者中呈悖论性升高，且在治疗前后均表现明显，尤其是TNFα-TNFR2相互作用更为突出。阻断这一信号轴（无论是否联合化疗）均能显著抑制肿瘤生长，且未观察到明显毒性。我们的研究强调了应激程序化效应型调节性T细胞在肿瘤免疫编辑中的作用，以及TNFα-TNFR2轴在新辅助化疗耐药机制中的关键地位，并支持其作为乳腺癌潜在治疗靶点的合理性。

### 第二部分 AI 大师评价

该研究旨在揭示乳腺癌新辅助化疗耐药过程中免疫微环境的关键调控机制。通过单细胞转录组学分析，作者识别出一个保守的“应激程序化”免疫模块，其通过TNFα-TNFR2信号轴促使调节性T细胞获得效应型特征，从而削弱化疗疗效。实验验证表明，阻断该信号可显著抑制肿瘤生长且无显著毒性，揭示TNFR2+ Treg在肿瘤免疫耐药中的核心作用。研究创新性地将应激信号与免疫耐药连接，提出TNFα-TNFR2通路作为新辅化抗性治疗靶点，但其临床可转化性仍需进一步验证。

---

速递结束，祝您工作愉快！